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Background. Vinyl chloride (VC) is an environmental toxicant and has been 
shown to be directly hepatotoxic at high exposures. However, recent studies 
suggest low-level toxicant exposure can cause subtle changes to the liver. Given 
the high prevalence of non-alcoholic fatty liver disease (NAFLD) in the United 
States, it is important to determine the impact of low-level toxicant exposure on 
the progression of underlying liver injury when combined with other factors. 
Therefore, the overarching goal of this dissertation was to develop a model of VC 
co-exposure with high-fat diet (HFD) and to determine the mechanisms by which 
VC contributes to the development of liver injury. Methods. Mice were fed a low 
fat diet (LFD) or high fat diet (HFD) and exposed to sub-OSHA levels of VC (0.85 
± 0.1 ppm) or room air 6 hours per day, 5 days per week, for either 6, 8, or 12 
weeks. Metabolic phenotyping, biochemical and histological assessment of liver 
injury, indices for oxidative and endoplasmic reticulum (ER) stress, and 
vi 
 
mitochondrial function were examined for each time point. Results. Chapter III of 
this dissertation describes a VC inhalation model in which co-exposure to a HFD 
significantly enhances liver injury associated with NAFLD. Specifically, mice 
exposed to both VC and HFD had significantly enhanced indices of liver injury, 
inflammation, and cell death. In Chapter IV, metabolic dyshomeostasis is 
evaluated as a mechanism by which VC exposure sensitizes the liver to 
secondary insults. Indeed, mice exposed to VC alone had significant alterations 
in glucose homeostasis in addition to enhanced oxidative and ER stress. Finally, 
Chapter V examines the effect of VC exposure on mitochondrial integrity and 
function. Importantly, VC’s detrimental effect on mitochondria is specific to 
enzymes involved in oxidative phosphorylation, rather than general mito-toxic 
action. Discussion. In conclusion, the work presented in this dissertation has 
shown that sub-OHSA levels of VC exposure are sufficient to enhance underlying 
liver injury. Moreover, VC exposure can cause metabolic disruption even in 
combination with a LFD. VC directly targets complexes of oxidative respiration 
which sensitize hepatocytes to subsequent injury and cell death.   
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A. Background and rationale for this study  
 
1. Liver function as a target for toxicity 
The liver has several important metabolic and physiologic functions. It is 
the primary site of dietary nutrient conversion, storage, and supply for other 
organs and also facilitates the removal of toxic compounds from the body. The 
central location of the liver enables it to function as both a biochemical and 
physical filter in order to protect other organs from exposure to potentially toxic 
compounds. By virtue of its function, the liver is often a target of toxicant 
exposure and injury. Liver function can be influenced by several factors such as 
alcohol consumption, genetics, and diet composition. The main hepatic cell type 
that functions to maintain nutritional homeostasis via synthesis and secretion of 
major carbohydrate and lipid molecules are hepatocytes. Hepatocytes constitute 
approximately 80% of the liver by mass and express specific enzymes that allow 
for detoxification and nutrient metabolism (1). 
 In addition to hepatocytes there are also several other non-parenchymal 
cell types in the liver which are vital to its overall health and function such as 
Kupffer cells (resident hepatic macrophages) and hepatic stellate cells. These 
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cells play a pivotal role in contributing to local inflammation, recruitment of other 
immune cells, and formation of extracellular matrix proteins, all of which 
contribute to liver disease and injury progression (2).  
The hepatic portal vein receives blood and compounds directly from the 
intestines and ensures that nutrient breakdown occurs and harmful chemicals are 
removed prior to reaching system circulation. As such, hepatocytes are equipped 
with various enzymes that are capable of metabolizing and detoxifying chemicals 
to mitigate such potentially damaging compounds. The most diverse and 
prominent class of enzymes are the mixed function oxidases, also known as the 
cytochrome P450 family of enzymes. These enzymes are able to metabolize a 
variety of drugs, chemical compounds, and toxicants (3). However, because 
CYPs often execute Phase I metabolic reactions, the end result is commonly 
activation of the compound to form reactive intermediates or metabolites, which 
may cause more harm than the parent compound. For example, reactive 
metabolites can form protein or DNA adducts, subsequently inciting a local 
inflammatory response. Therefore, hepatocytes are often the initial and primary 
target of damage caused by chemical and/or toxicant exposure. However, 
hepatocytes have the capacity to regenerate in order to prevent such injuries and 
preserve the health and function of the entire organ. Although this protective 
mechanism serves as a defense against damage, the regenerative capacity of 
the liver is limited. If the damage is too severe or if the injury is chronic, hepatic 




2. VOCs: prevalence and hepatotoxicity  
Volatile organic compounds (VOCs) are chemicals that easily vaporize. 
Ambient levels are often higher indoors than outdoors, and concentrations can 
be significantly affected by how often windows are opened and the location of the 
building or residence (i.e., proximity to industrial and traffic pollution) (4-6). 
Additionally, VOCs are often ingredients in common household products such as 
paints, varnishes, cleaning supplies, degreasing agents, gasoline, and dry-
cleaned clothing (7). As such, the typical route for human exposure is via 
inhalation or dermal absorption (7). However, VOCs are also common ground 
water contaminants as they are present at many waste disposal sites and are the 
most common class of chemical found at National Priority List (NPL) Superfund 
sites. A substantial number of compounds on the ‘ATSDR hazard substance 
priority list’ represent VOCs, with many in the top 50 chemicals (8). Although 
there have been several instances of mass exposure to VOCs, one of the more 
studied cases is from the Camp Lejeune military base in North Carolina. Up to 1 
million people, including military personnel and their families, were exposed to a 
mixture of VOCs (TCE, PCE, benzene, and VC) via contaminated drinking water 
in the 1980s (9). A retrospective mortality cohort study demonstrated increased 
mortality and deaths from cancer, including liver, in personnel exposed at Camp 
Lejeune compared to a non-contaminated military base (10). However, other 
health effects and long-term outcomes are still being evaluated. 
Although researching these compounds in the context of occupational 
exposures (i.e., acute, high doses) has been invaluable for characterizing 
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hepatotoxicity and developing risk assessment models, the field has begun to 
shift away from this exposure model.  
3. Vinyl chloride 
Vinyl chloride (VC) is a common VOC and is ranked #4 on the ATSDR 
Substance Priority List with a global annual production estimated at 27 million 
tons and a global capacity of 40 million tons (11). It is colorless when liquefied 
under pressure and at high volumes has sweet-smelling odor. VC is a chemical 
monomer that is used in the commercial production of polyvinyl chloride (PVC) 
polymer resins or plastics. VC has been used commercially in the United States 
for over 70 years and has been characterized as a Group A human carcinogen 
by the EPA and as a Group 1 known human carcinogen by IARC. One of the 
major methods of VC production is by subjecting 1, 2-dichloroethylene to 
extreme pressure and temperature, a process known as thermal cracking, which 
results in VC synthesis. PVC has a wide range of uses in the production of pipes, 
pipe fittings, windows, doors, flooring, and plastic products with both residential 
and commercial applications (12).  
VC was first recognized as a direct hepatotoxicant and carcinogen in 1974 
by Drs. Creech and Johnson (13;14). Several VC factory workers at the B.F. 
Goodrich facility in Louisville, KY presented with a rare form of liver cancer, 
hepatic angiosarcoma. These workers were occupationally exposed to VC at 
extremely high levels up to 1,000 ppm. Due to the extreme rarity (fewer than 200 
cases diagnosed annually worldwide (15)) of this cancer and the clustering of 
diagnoses, VC was recognized as the causative agent. Indeed, other reports also 
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suggest a direct correlation between occupational exposures to VC and 
development of this hepatic cancer (16). In 1975, the Occupational Safety and 
Health Administration (OSHA) evaluated the safety guidelines for VC exposure 
and established a guideline and exposure threshold for occupational exposure to 
VC. The current OSHA threshold for VC exposure is a time-weighted average of 
no more than 1 ppm over an 8-hour work day, and no more than 5 ppm in a 15 
minute period (OSHA Vinyl Chloride Standard 29 CFR 1910.1017)(17).  
The main route of VC exposure is via inhalation. VC absorption into the 
circulation is rapid, has a wide distribution, and it acts systemically. The half-life 
of VC is only a few hours. Given the high reactivity of its metabolic intermediates 
(see below) it is unlikely that VC gas directly damages tissue. The main site of 
the enzymes that metabolize VC are located in the liver, as a consequence, the 
liver is exquisitely sensitive to VC exposure. As mentioned earlier in this Chapter 
(Section 1), this allows the liver to counteract any harmful effects that might be 
caused by such chemicals to prevent them from entering systemic circulation. VC 
is metabolized in a very similar manner as ethanol. A major pathway of VC 
metabolism is via the cytochrome P450 enzyme, CYP2E1. CYP2E1 catalyzes a 
Phase I reaction in which VC is oxidized to the highly reactive epoxide, 2-
chloroethylene oxide. This can then be conjugated to glutathione in a Phase II 
reaction and subsequently excreted. 2-chloroethylene oxide (CEO) can also 
spontaneously rearrange to form a reactive aldehyde species, 2-
chloroacetaldehyde (CAA). Another pathway of VC metabolism is its oxidation to 
2-chloroethanol (CE). CE is also metabolized into 2-chloroacetaldehyde (CAA) 
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via alcohol dehydrogenase. CAA, from either metabolic pathways, then enters 
into a subsequent reaction catalyzed by aldehyde dehydrogenase to form 
chloroacetic acid. These intermediates are detoxified via glutathione conjugation 
and excreted in the urine, commonly as thioacetic acid (18;19). Further, sentinel 
studies performed during the 1970s and 1980s provided essential insight into the 
mechanisms by which VC is metabolized. From these studies it has been shown 
that chloroethylene oxide and chloroacetaldehyde are the major reactive 
intermediates formed through VC metabolism. Both are highly electrophilic and 
as such are able to attach nucleophilic biomolecules such as lipids, DNA, RNA, 
and proteins. Chloroethylene oxide has been shown to be a potent mutagen, 
targeting DNA, while chloroacetaldehyde is more specific forming protein adducts 
(19-22).  
Historically, research regarding VC hepatotoxicity has focused on its 
mutagenicity and carcinogenicity. These studies have employed acute exposure 
paradigms and high levels of VC exposure (23;24). More recently, Swenberg et 
al., has shown that VC exposures at concentrations ranging from 10-1,100 ppm 
are sufficient to give rise to harmful DNA adducts (25). However, little work has 
been done on lower exposure levels and the potential for overlap with other risk 
factors for liver disease.  
Recently, work from the Beier laboratory has focused on the reactive 
metabolic VC intermediates, CE and CAA. Indeed, data from this work have 
shown that exposure to these metabolites sensitize hepatocytes to injury from a 
secondary stimulus. These studies show that sub-hepatotoxic doses of CE are 
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sufficient to alter hepatic metabolism and enhance damage when combined with 
another factor in vivo (26;27). Additionally, CAA has been shown to be directly 
toxic to mitochondria (28). 
4. Natural history of liver disease  
Liver disease is not one pathology; rather, it is classified as a spectrum of 
disorders that range in severity from relatively benign to end-stage liver disease 
(29). Typically, the first stage of liver disease is identified by an accumulation of 
lipids within hepatocytes, termed steatosis. The exact mechanism which causes 
the influx of lipids can be variable; however, the end result is unbalanced lipid 
and mitochondrial homeostasis. If this metabolic disruption is continued 
chronically, it can cause an inflammatory response or steatohepatitis. 
Steatohepatitis is characterized as persistent lipid accumulation within the liver in 
addition to active inflammation (hepatitis). If the damaging factor is not mitigated, 
injury is progressive and can develop into more severe phenotypes such as 
fibrosis and cirrhosis, characterized as end-stage liver disease. Fibrosis and 
cirrhosis are characterized by an accumulation of extracellular matrix proteins, 
regenerative nodules, and scar tissue. These may ultimately lead to the 
development of hepatocellular carcinoma.  
Interestingly, not all patients who have liver disease will develop severe 
liver injury. Several studies have now established that the development of liver 
disease is not attributable to solely one factor (30;31). Rather, liver disease 
progression can be influenced by a variety of factors ranging from genetics to 
diet composition and nutrient intake and exists as a ‘multi-hit’ paradigm of 
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development. As such, multiple factors must be taken into consideration when 
studying liver disease progression. Although the progressive nature of liver 
disease is consistent regardless of the source of injury, several unique etiologies 
have been characterized. These include alcoholic (ALD), non-alcoholic (NAFLD), 
and toxicant-associated (TAFLD) fatty liver diseases (32).  
The liver is not a static organ and is able to respond dynamically to 
stressors and injury. It is now well-characterized that the liver can be sensitized 
to damage by a secondary agent, causing more damage than either factor 
individually. This paradigm allows a broader scope for research and introduces 
the potential for interactions with other to influence and enhance underlying liver 
injury. Liver damage occurs in a ‘multiple-hit”’ paradigm, in which chronicity and a 
combination of genetic, environmental, and intracellular events determine 
disease progression (33).  
5. Environmental liver disease: TASH 
Toxicant-associated fatty liver disease and steatohepatitis (TAFLD, TASH, 
respectively) have recently been characterized by the Cave laboratory. TASH is 
unique from the other forms of liver disease in that patients who present with 
pathologies do not have the classic risk factors associated with liver disease 
such as alcohol consumption or being overweight. In 2010, Cave et al., analyzed 
several biopsies and serum from highly exposed VC chemical plant workers that 
were collected subsequent to the hepatic angiosarcoma diagnoses in order to 
better understand the health effects in this unique population. Patients did not 
have the typical serum elevation of liver enzymes (i.e. transaminases) that are 
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clinically associated with liver injury. However, upon histologic evaluation of 
these samples, pathologic indices of liver injury including steatosis, 
steatohepatitis, and fibrosis were elevated. In fact, of the 25 subjects examined, 
80% had steatohepatitis as evidenced via histology and 55% of that subset had 
fibrosis (34). Importantly, this study concluded that the liver injury present was 
contributable to their occupational exposures to VC and not to another factor. 
Indeed, other studies have noted development of severe liver injury in industrial 
chemical workers (35;36).  
Since OSHA set stricter exposure guidelines for industrial exposure to VC, 
the opportunity for such high, acute exposures are significantly decreased. 
However, little research has been conducted on the effect of this low-level VC 
exposure over an extended timeline in either the occupational or environmental 
context. Moreover, there is little known regarding low level VC exposure and how 
it may act to enhance underlying liver injury, such as that caused by obesity.  
6. Obesity and NAFLD 
Obesity is growing health concern both in the United States and globally 
and is caused by excessive caloric intake and overconsumption of dietary fats 
and characterized by abdominal fat accumulation. According to the World Health 
Organization (WHO), worldwide obesity has nearly tripled since 1975 (37). In 
2016, it was estimated that 1.9 billion adults were overweight (BMI>25 kg/m2) 
worldwide with 650 million being classified as obese (BMI>30 kg/m2)(37). In the 
United States alone, more than 2/3 (70.2%) of adults are considered overweight 
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or obese (38) causing a substantial burden with the medical cost associated with 
obesity-related health concerns being 147 billion dollars in 2008 (39).  
Obesity has many associated detrimental health effects including 
cardiovascular disease, type 2 diabetes, and metabolic syndrome. Metabolic 
syndrome is a collective term for obesity-associated malignancies such as insulin 
resistance, hypertension, and dyslipidemia (40). NAFLD is the hepatic 
manifestation of metabolic syndrome and as such it is closely correlated with 
incidence of obesity. Given the high prevalence of overweight and obesity 
globally, it is not surprising that the worldwide burden of NAFLD substantial. 
Younossi et al., has recently performed a meta-analyses yielding that 25% of the 
global population has underlying NAFLD (41;42). As mentioned above, not all 
patients diagnosed with NAFLD will go on to develop non-alcoholic 
steatohepatitis (NASH)(43;44). This is a critical fact to consider when studying 
liver disease risk, as other risk-modifying factors may be involved in disease 
progression to more severe pathologies.  
 There are several risk-factors associated with NAFLD severity including 
genetic variations in key genes (45). One of the most well-known single 
nucleotide polymorphisms is in the Pnpla3 gene which is involved in hepatic lipid 
processing. Populations which express a specific variant of this gene are more 
susceptible to develop NAFLD (46;47). However, other comorbidities such as 
alcohol consumption and environmental toxicant exposures may also influence 
risk for disease. As such, it is critical that multiple factors are considered when 
studying liver disease. In that regard, the field of hepatology has begun to 
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evaluate a multi-factor approach for NAFLD and ALD influence on disease 
progression (48).  
One of the research goals of the Beier laboratory is to study the effects of 
chronic, low-level VC exposure on liver health and the potential interactions with 
underlying liver injury, such as early stages of NAFLD. As previously mentioned, 
studies from this laboratory have established that VC metabolites enhance 
severity of liver injury when combined with another factor such as an 
inflammatory stimuli (LPS, (26)) or high-fat diet feeding (HFD, (27)). The field of 
environmental toxicology has already begun to shift towards a more integrated 
approach on studying how toxicants may act to enhance pre-existing organ 
injury. 
 
7. Statement of goals  
As discussed throughout this Chapter, the development of liver disease is a 
complex and incompletely understood process. Although there are known risk 
factors for progression of liver disease, in order to better simulate human 
disease, multiple risk factors must be taken into consideration when studying 
liver disease development. As discussed in Sections 5 and 6, both toxicant 
exposure and NAFLD are major contributors for liver disease. Additionally, as 
mentioned in Section 3, although acute toxicity for VC has been studied, there is 
a knowledge gap regarding the effects of low-level, chronic VC exposure. Given 
the high prevalence of obesity and the occurrence of significant risk for exposure 
to VC from both Superfund and industrial sites, there is a high likelihood of 
12 
 
exposure overlap. Therefore, the purpose of this dissertation will be to prove the 
hypothesis that low-level VC exposure interacts and enhances NAFLD and to 
investigate the mechanisms by which VC induces hepatocyte susceptibility to 
injury. These goals will be discussed in detail in the following section.  
 
B. Aims and Proposals  
 
1. Develop and characterize an animal model of NAFLD and low-
level VC exposure and determine if VC enhances NAFLD 
This dissertation proposes that low-level VC exposure can interact with 
underlying liver injury to enhance damage. This will provide novel insight into 
environmentally relevant levels of VC exposure in conjunction with ingestion of a 
diet rich in fatty acids (high fat diet, HFD). Previous work has used VC 
metabolites as a surrogate for VC exposure instead of the parent VC gas. 
Therefore, the goals if the first Aim of this dissertation are to, 1.) Develop and 
characterize a model for concomitant low-level VC exposure via inhalation and 
HFD feeding to better mimic human exposure paradigms, 2.) Evaluate indices of 
liver injury and inflammation to determine if VC exposure enhances NAFLD-
induced liver injury, and 3.) Determine the major cell death pathways involved in 
this model of injury, which will provide mechanistic insight into how VC 
contributes to liver damage.  
2. Determine mechanisms by which VC enhances NAFLD via 
metabolic dysregulation and oxidative stress 
As mentioned previously, Anders et al ., has demonstrated that VC 
metabolites exacerbate liver injury both via inflammatory and metabolic pathways 
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(26;27). Intriguingly, work from those same studies reveal that metabolite 
exposure alone is sufficient to alter metabolic homeostasis in vivo by causing 
alterations of key pathways involved in energy and nutrient metabolism. 
Additionally, CE was found to enhance hepatic endoplasmic reticulum (ER) and 
oxidative stress. Therefore, the goals of this aim are to build upon these previous 
observations and to evaluate their role in a more relevant mouse model. 
Accordingly, the goals of Aim 2 of this dissertation are to, 1.) Determine if sub-
OSHA concentrations of VC exposure alone, absent any other stimulus, are 
sufficient to alter hepatic metabolism and, 2.) Evaluate if ER and oxidative stress 
play a role in the enhancement of liver injury observed with the combination of 
VC and a HFD. 
3. Determine the effect of VC exposure on mitochondrial integrity 
and function 
Mitochondria are vital to the health and function of all cell types. They are 
critical producers of cellular energy, key regulators of cellular energy metabolism, 
and are important modulators of cell death pathways. If any of their functions are 
perturbed, cellular processes can become deranged and have biochemical and 
physiological consequences. Indeed, mitochondrial dysfunction is known to play 
a part in development of NAFLD and several other types of liver injury. The Beier 
lab has investigated mitochondrial damage with VC metabolite exposure, 
specifically chloroacetaldhyde (CAA), in vitro, both in cultured and primary 
hepatocyte models. These studies revealed that CAA decreases mitochondrial 
respiration, decreases cellular ATP levels, and depolarizes mitochondrial 
membrane potential in a concentration dependent manner (26). However, it is 
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unknown how sub-OSHA levels of VC exposure via inhalation affect 
mitochondrial dynamics in vivo. As such, the goals for Aim 3 of this dissertation 
are to, 1.) Evaluate the effect of VC and diet on mitochondrial respiration in vivo, 
and 2.) Determine the mechanisms by which VC affects mitochondrial respiration 
and energy production in hepatocytes.  
Overall aim of this dissertation  
 The overall aim of this dissertation is to address the unifying hypothesis 
that low-level VC exposure may be sufficient to enhance underlying liver disease. 
As discussed above, high-level exposures to VC have been characterized, but 
the effect of lower, chronic exposures have not been studied, nor has low-level 
VC exposure been studied in the context of experimental NAFLD. Therefore, this 
question will be addressed in Aim 1. Additionally, recent data from this group 
have determined that sub-hepatotoxic concentrations of VC metabolites can 
influence hepatic metabolism and induction of ER stress. The effect of sub-
OSHA exposures to VC via inhalation on hepatic metabolism and stress 
responses would be informative to establish. Therefore, this will be the major 
goal of Aim 2. Finally, mitochondrial dynamics are crucial for whole cell 
homeostasis. VC metabolites and other environmental toxicants are known to 
disrupt mitochondrial function and respiration. However, the effect of direct 
exposure to VC via inhalation, with and without the co-exposure of high fat diet, 
on mitochondrial integrity and respiration has not been studied. Aim 3 will serve 
to address this question. Taken together, this dissertation will provide novel 
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insight into sub-OSHA exposures of VC and its impact on liver health when 






CHAPER II  
  
EXPERIMENTAL PROCEDURES  
  
A. Animals and Treatments  
Six week old, male C57BL/6J mice from Jackson Laboratory (Bar Harbor, 
ME) were housed in a pathogen-free barrier facility accredited by the Association 
for Assessment and Accreditation of Laboratory Animal Care, and procedures 
were approved by the University of Louisville’s Institutional Animal Care and Use 
Committee. Animals were housed in shoebox cages with corncob bedding and 
were allowed food and water ad libitum on a 12 hour light/dark cycle.  
1. Chronic model of VC exposure  
The exposure paradigm used was modified from Drew et al. Mice were 
chronically exposed to VC at 0.85 ± 0.1 ppm, or room air, for 6 hours per day, 5 
days per week, for a maximum of 12 weeks (49). Mice were exposed in a state-
of-the-art 2-tiered inhalation chamber system capable of performing 
simultaneous exposures with up to 100 mice at one time (50 mice/tier) housed at 
the UofL CTRB barrier facility designed with extensive housing capacity, card-
coded entry, and separate HVAC system to maintain barrier, temperature and 



















Scheme 2.1. Model of chronic VC co-exposure with HFD feeding. Mice were 
fed either a low fat control diet (LFD) or a high fat diet (HFD) and were exposed 
to vinyl chloride for up to 12 weeks. Animals were euthanized at 6, 8, and 12 
weeks of exposure.  
  
Week 0
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 Mice were allowed food and water ad libitum the entire course of the 
study. Mice were fed LFD or HFD (Envigo, Teklad Diets, Madison, WI). Body 
weight for each animal was measured once per week and food consumption was 
monitored and recorded twice per week. Animals were euthanized at 6, 8, and 12 
weeks of exposure (Scheme 2.1).  
2. Animal sacrifice, tissue collection, and storage  
At the time of sacrifice, 4 hour fasted animals were anesthetized with 
ketamine/xylazine (100/15 mg/kg, i.p.). Blood was collected from the inferior vena 
cava just prior to sacrifice by exsanguination and citrated plasma was stored at -
80°C for further analysis. Portions of liver tissue were snap-frozen in liquid 
nitrogen, embedded in frozen specimen medium (Sakura Finetek, Torrance, CA), 
or were fixed in 10% neutral buffered formalin for subsequent sectioning and 
mounting on microscope slides.  
3. Key chemical resources 
VC obtained from Kin-Tek (La Marque, TX) was validated by the Kentucky 
Institute for the Environment and Sustainable Development of the University of 
Louisville and was stored at -20°C in the barrier facility when not in use. The VC 
concentration in the inhalation chamber was measured by gas 
chromatography/mass spectrometry (GC/MS) in full scan mode according to the 
EPA method TO-15, using a quadrupole GD (HP 6890) with a HP 5973 Mass 
Selective Detector. Grab air samples from the inhalation chamber were collected 




Low fat diet (LFD). 13% calories as fat; Casein 195.0 g/kg, DL-Methionine 
3.0 g/kg, Sucrose 120.0 g/kg, Corn Starch  432.89 g/kg, Maltodextrin 100.0 g/kg, 
Anhydrous Milkfat 37.2 g/kg, Soybean Oil 12.8 g/kg, Cellulose 50 g/kg, Mineral 
Mix, AIN-76 (170915) 35.0 g/kg, Calcium Carbonate 4.0 g/kg, Vitamin Mix, 
Teklad (40060) 10.0 g/kg, Ethoxyquin, antioxidant 0.01 g/kg; (Envigo Teklad 
Diets, Madison, WI). 
High fat diet (HFD). 42% calories as fat; Casein 195.0 g/kg, DL-
Methionine 3.0 g/kg, Sucrose 341.31 g/kg, Corn Starch 75.0 g/kg, Maltodextrin 
75.0 g/kg, Anhydrous Milkfat 210.0 g/kg, Cholesterol 1.5 g/kg, Cellulose 50.0 
g/kg, Mineral Mix, AIN-76 (170915) 35.0 g/kg, Calcium Carbonate 4.0 g/kg, 
Vitamin Mix, Teklad (40060) 10.0 g/kg, Ethoxyquin, antioxidant 0.04 g/kg; 
(Envigo Teklad Diets, Madison, WI).  
5. Metabolic Phenotyping  
Oxygen consumption rates, carbon dioxide production rates, respiratory 
exchange ratios, food and water consumption an activity (sum of ambulatory and 
fine movements) of animals were measured using a physiologic/metabolic cage 
system (TSE Phenomaster System, Bad Homberg, Germany) during the dark 
cycle for each of the 3 time points. Body composition was measured using dual-
energy x-ray absorptiometry (DEXA) mouse densitometer (PIXImus2, Lunar, 
Madison, WI) at 6, 8, and 12 weeks of exposure (Scheme 2.1).  
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Pyruvate tolerance test (1g/kg, PTT) and insulin tolerance test (0.75 U/kg, 
ITT) were performed at 6 weeks of exposure and oral glucose tolerance test 
(2g/kg, OGTT) was performed at 6 and 11 weeks. Animals were fasted overnight 
prior to the PTT and for 6 hours prior for both the ITT and OGTT. Blood was 
sampled from the tail vein and blood glucose measurements were taken using an 
AccuCheck Aviva Plus glucometer and test strips (Roche, Indianapolis, IN). 
Measurements were taken at 0, 15, 30, 60, 90, and 120 minutes after 
administration of each compound. 
Hepatic mitochondria were isolated as previously described (50). Briefly, 
crude mitochondria were isolated by differential centrifugation using a Beckman 
Coulter Avanti Ultracentrifuge (J26xPI, rotor: JA 25.50). Liver homogenates were 
centrifuged two times at 700g for 5 minutes at 4°C, supernatants were retained 
and the pellet (unbroken cells and nuclei) was discarded. After the second spin, 
the supernatant was collected and centrifuged at 9,000g for 10 minutes at 4°C. 
The resulting supernatant (cytosolic fraction) was discarded and the pellet (crude 
mitochondria) was collected and centrifuged two times at 10,000g for 10 minutes 
at 4°C. After the final spin, the crude mitochondrial pellet was resuspended in 
2mL of mitochondrial resuspension buffer (250mM mannitol, 5mM HEPES, 
0.5mM EGTA). Lowry protein determination assay was performed on all samples 
and samples were plated on XF96 culture plates at 15μg/μl. 
Pyruvate/malate/ADP (Complex I substrates; 5mM/2.5mM/1mM), oligomycin 
(Complex IV inhibitor; 1μg/mL), FCCP (mitochondrial uncoupler; 4μM), and 
succinate/rotenone (Complex II substrates; 10mM/1μM) were administered. 
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Oxygen consumptions rates were subsequently measured with a Seahorse XF96 
extracellular flux analyzer (Agilent, Santa Clara, CA).  
B. Histology  
1. General morphology  
Formalin fixed, paraffin embedded liver tissue was sectioned at 5 µM and 
mounted on charged glass slides. Sections were deparaffinized with Citrosolv 
(Fisher Scientific, Waltham, MA) and rehydrated through addition of graded 
ethanol solutions. Sections were then stained with hematoxylin and eosin (H&E). 
After staining, samples were dehydrated through graded ethanol, washed in 
Citrisolv and mounted with Permount (Fisher, Waltham, MA).  
2. Neutrophil accumulation  
Neutrophil accumulation in liver tissue was assessed using chloroacetate 
esterase (CAE) staining. Formalin fixed, paraffin embedded liver tissue was 
sectioned at 5 µM and mounted on charged glass slides. Sections were 
deparaffinized with Citrisolv (Fisher, Waltham, MA) and rehydrated through 
addition of graded solutions of ethanol. Sections were incubated in a solution of 
napthol AS-D chloroacetate (1mg/mL) in N,N-dimethylformamide, with a 4% 
sodium nitrite and 4% new fuschin (Sigma - Aldrich, St. Louis, MO). The AS-D is 
enzymatically hydrolyzed by chloroacetate esterase in neutrophils, freeing the 
napthol compound. Napthol then combines with the freshly formed diazonium 
salt, resulting in bright pink deposits at the site of the enzymatic activity, which 
can then be visualized and quantified.  
22 
 
3. Oxidative Stress 
Lipid peroxidation adducts were visualized by 4-hydroxynonenal (4-HNE) 
staining. Liver sections (5 µM) were deparaffinized with Citrsolv (Fisher, 
Waltham, MA) and rehydrated through graded ethanol. To prevent background 
binding, sections were incubated in a peroxidase blocking buffer for 5 minutes 
(Dako North America Inc, Carpinteria, CA). Slides were washed and incubated 
with 4-HNE rabbit anti-mouse primary antibody (1:500; Alpha Diagnostics, San 
Antonio, TX) for 30 minutes at room temperature. Slides were washed again and 
secondary antibody was applied for 15 minutes at room temperature. Slides were 
washed again and DAB solution was applied for visualization of positive (brown) 
staining. Slides were then rinsed in water and counterstained with hematoxylin. 
Sections were dehydrated through graded ethanol and Citrisolv, and mounted 
with Permount.  
Malondialdehyde (MDA) adducts were visualized by a similar 
immunohistochemical staining procedure. Liver sections (5 µM) were 
deparaffinized with Citrisolv (Fisher, Waltham, MA) and subsequently rehydrated 
through graded ethanol. Target retrieval was performed overnight at 72°C. The 
next day, sections were incubated with a 3% hydrogen peroxide blocking buffer 
to prevent any endogenous peroxidase activity. Sections were incubated with 
avidin and biotin blocking reagents for 5 minutes at 30°C (Life Technologies, 
Frederick, MD) to quench excess tissue biotin. To further minimize non-specific 
binding, sections were incubated with 10% goat serum for 30 minutes at room 
temperature. Monoclonal rat anti-mouse primary antibody for MDA (1:500; Alpha 
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Diagnostics, San Antonio, TX) was applied to the positive section and allowed to 
incubate for 2 hours at room temperature, while the negative sections received 
non-antibody containing buffer. Biotinylated anti-rat secondary antibody was 
applied to both positive and negative sections for 15 minutes at room 
temperature. Slides were washed and an avidin-HRP solution was applied for 30 
minutes at room temperature. Slides were rinsed and DAB solution was added to 
visualize positive (brown) staining. Slides were washed with water and 
counterstained with hematoxylin. Sections were dehydrated through graded 
ethanol, Citrisolv, and mounted with Permount.  
4. Macrophages  
Hepatic macrophages were visualized via immunohistochemistry. Liver 
sections (5 µM) were deparaffinized with Citrisolv (Fisher, Waltham, MA) and 
subsequently rehydrated through graded ethanol. Target retrieval was performed 
overnight at 72°C. The next day, sections were incubated with a 3% hydrogen 
peroxide blocking buffer to prevent any endogenous peroxidase activity. Sections 
were incubated with avidin and biotin blocking reagents for 5 minutes at 30°C 
(Life Technologies, Frederick, MD) to quench excess tissue biotin. To further 
minimize non-specific binding, sections were incubated with 10% goat serum for 
30 minutes at room temperature. Monoclonal rat anti-mouse primary antibody for 
F4/80 (1:50; Abcam, Cambridge, MA) was applied to the positive section and 
allowed to incubate for 2 hours at room temperature, while the negative sections 
received non-antibody containing buffer. Biotinylated anti-rat secondary antibody 
was applied to both positive and negative sections for 15 minutes at room 
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temperature. Slides were washed and an avidin-HRP solution was applied for 30 
minutes at room temperature. Slides were rinsed and DAB solution was added to 
visualize positive (brown) staining. Slides were washed with water and 
counterstained with hematoxylin. Sections were dehydrated through graded 
ethanol, Citrisolv, and mounted with Permount. 
5. Fibrin  
Immunofluorescent detection of fibrin accumulation has been described 
previously (51), and was conducted with minor modifications. Liver sections (5 
µM) were deparaffinized with Citrisolv (Fisher, Waltham, MA) and rehydrated 
through graded ethanol. Autofluorescence of paraffin-embedded tissue was 
quenched with 70% ethanol containing 0.25% NH4OH for 1 hour at room 
temperature during deparaffinization. Proteolytic digestion was performed by 
incubating tissue sections in 0.03% Pronase E (Sigma-Aldrich, St. Louis, MO) for 
10 minutes at 37°C, sections were then incubated in sodium borohydride (10 
mg/mL) for 40 minutes at room temperature for additional autofluorescence 
quenching. To minimize non-specific antibody binding, sections were incubated 
in 10% goat serum in PBS for 30 minutes at room temperature. Sections were 
then incubated with rabbit polyclonal anti-fibrinogen (Agilent Technologies 
A0080, Santa Clara, CA) in blocking buffer (1:1000) overnight at 4°C. The next 
day, sections were washed in PBS and incubated with AlexaFluor 488 goat anti-
rabbit secondary antibody (1:500; Life Technologies, Carlsbad, CA) in blocking 
buffer for 3 hours at room temperature. After washing, slides were mounted with 
VECTASHIELD Antifade Mounting Medium with DAPI (Vector Labs, Burlingame, 
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CA). Slides were visualized with a Nikon Eclipse E600 microscope (Nikon 
Corporation, Tokyo, Japan) using Metamorph software (Molecular Devices, 
Sunnyvale, CA).  
6. Apoptosis 
Apoptosis was detected via terminal deoxynucleotide transferase biotin-
dUTP nick end labeling (TUNEL; Millipore, Billerica, MA). Briefly, formalin fixed, 
paraffin embedded liver tissue was sectioned at 5 µM and mounted on charged 
glass slides. Sections were deparaffinized with Citrisolv (Fisher, Waltham, MA) 
and rehydrated through graded ethanol. Tissue samples were processed 
according to the TUNEL kit protocol.  
7. Metabolism  
Neutral lipid accumulation was detected via Oil Red-O (ORO) staining. 
Liver tissue was embedded in Tissue-Plus optimal Cutting Temperature (OCT) 
embedding medium (Sakura Finetek, Torrance, CA) by freezing in liquid nitrogen. 
After embedding, samples were brought to -20°C and sectioned at 10 µM on a 
Leica cryostat. Sections were then stained with Oil Red-O solution (Sigma-
Aldrich, St. Louis, MO), washed, and counterstained with hematoxylin for 45 
seconds. Samples were mounted with Permount (Fisher, Waltham, MA). Hepatic 
glycogen reserves were visualized as a dark purple color using Periodic-Acid 
Schiff (PAS) staining. Formalin fixed, paraffin embedded liver tissue was 
sectioned at 5 µM and mounted on charged glass slides. Sections were 
deparaffinized with Citrisolv (Fisher, Waltham, MA) and rehydrated through 
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graded ethanol. Sections were incubated in 0.5% Periodic Acid solution for 5 
minutes. Samples were counterstained with hematoxylin for 45 seconds, washed 
in water, dehydrated through graded ethanol, washed in Citrisolv, and then 
mounted with Permount.  
8. Histology quantification  
Quantification of CAE staining was performed using Image J software in 
which CAE positive (bright pink) cells were counted and analyzed as positive 
cells out of 1,000 hepatocytes. Similarly, TUNEL positive (brown) cells, both 
hepatocytes and non-parenchymal cells (NPCs) were counted and are 
expressed as positive cells out of 1,000 hepatocytes.  
Image analysis was performed to quantify areas of positive staining for fibrin, 
F4/80, 4-HNE, MDA, ORO, and PAS stains. Metamorph software (Molecular 
Devices, San Jose, CA) was used to analyze positive staining based on setting 
unique color thresholds for each stain examined. Positive area is expressed as a 
percent of total microscope field area.  
C. Clinical Chemistry  
1. Biochemical analyses 
Plasma activity levels of alanine aminotransferase (ALT) and aspartate 
aminotransferase (AST) were determined spectrophotometrically using standard 
kits (Thermo Fisher Scientific, Waltham, MA). Plasma levels of lactate and β-
hydroxybutyrate were determined using standard kits (Abcam, Cambridge, MA 
and Cayman Chemical, Ann Arbor, MI, respectively). Liver tissue levels of 
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Thiobarbituric Acid Reactive Substances (TBARS) were determined using a 
commercially available kit (R&D Systems, Minneapolis, MN).  
Hepatic lipids were extracted as described previously (52;53). Briefly, 
mouse liver (25-50 mg) was pulverized in a liquid-nitrogen cooler mortar and 
pestle. Pulverized liver tissue was incubated in a methanol:chloroform (2:1) 
mixture on ice for 30 minutes. After the incubation, extracts were centrifuged at 
900g for 10 minutes at 15°C. After centrifugation, lipids were contained within the 
chloroform layer and were removed with a glass syringe. Extracts were dried 
using nitrogen gas. The resulting pellets were resuspended in 5% fatty acid free 
bovine serum albumin and kept at -80°C. The lipid extracts were then analyzed 
for levels of triglycerides (TG), cholesterol, and free fatty acids (FFA) using 
commercially available kits (Thermo Scientific, Waltham, MA and Roche 
Diagnostics, Indianapolis, IN, respectively).  
2. Luminex  
Protein levels of IL-6, PAI-1, TNF-α, MCP-1, Resistin, Leptin, and Insulin 
were detected in citrated plasma using a commercially available Milliplex® 
mouse adipokine panel (Millipore, Billerica, MA). The plate was read using a 
Luminex 100 plate reader and Exponent software. The assay was performed 
according to the manufacturer’s recommendation. Plasma samples were 
analyzed undiluted on a clear bottomed black 96 well plate. Antibody-immobilized 
beads were added to each sample and incubated at 4°C overnight with gentle 
shaking. Detection antibody was added to wells and incubated for 1 hour with 
subsequent addition of streptavidin-phycoerythrin. Quantitative analysis was 
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performed using the Luminex 100 IS. Data capture and analysis were performed 
using the Luminex Xponent software.  
3. ELISA 
Plasma thrombin-antithrombin (TAT) complex levels were detected in citrated 
plasma using a commercially available ELISA kit (Abcam, Cambridge, MA) as 
described previously (51;54). 
D. Primary hepatocyte isolation 
Mouse hepatocytes were isolated and separated from anesthetized mice via 
collagenase perfusion from each treatment group at 6 weeks of exposure as 
previously described (55;56). Briefly, livers were perfused through the inferior 
vena cava (IVC) at a constant rate of 5mL/minute at 37°C. First, livers were 
perfused with an EGTA buffer for 6 minutes, followed by subsequent perfusion 
with collagenase buffer (0.36mg/mL) for 10 minutes. Livers were removed and 
immediately minced in Waymouth’s medium and the gallbladder was removed. 
The resulting suspension was filtered a sterile cell strainer (70µM; Corning Life 
Sciences, Tewksbury, MA). The suspension was centrifuged at 50g for 5 minutes 
at 4°C. Cells were washed two times with HBSS (Life Technologies, Grand 
Island, NY) followed by centrifugation at 50g for 5 minutes at 4°C. After the final 
spin, cell were resuspended in Waymouth’s media and viability was determined 
via Trypan blue exclusion.  
E. Quantitative cell analysis  
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Immediately following isolation, primary mouse hepatocytes were plated 
(10,000 viable cells/well) on collagen I coated 96 well plates (Life Technologies, 
Grand Island, NY). Cells were allowed to incubate for 90 minutes in Waymouth’s 
media supplemented with FBS and insulin transferrin solution (ITS) (Gemini Bio 
products, Life Technologies, Grand Island, NY). Cells were then incubated with 
media containing chloroacetaldehyde (CAA, Sigma-Aldrich, St. Louis, MO) from 
0 to 400 μM for one hour. CAA-containing media was removed and one hour 
prior to the commencement of measurements media containing: Hoechst 33342 
(12.5 µM; nuclear stain), tetramethylrhodamine (TMRM; 20 nM, mitochondrial 
membrane potential), and quinolinium, 1,1'-[1,3-propanediylbis[(dimethyliminio)-
3,1-propanediyl]]bis[4-[3-(3-methyl-2(3H)-benzothiazolylidene)-1-propen-1-yl]-
,iodide (1:4) (TOTO-3, 1µM, cell death) dyes were added to the wells (Invitrogen, 
Carlsbad, CA) . Following the one hour incubation with the dyes, the plate was 
placed into the Cellomics Array Scan VTI HCS reader and relative fluorescence 
units (RFU) were analyzed, as described previously (57). 
F. RNA isolation and quantitative reverse-transcription polymerase 
chain reaction 
Total RNA was extracted from liver tissue by a guanidinium thiocyanate-
based method (RNA STAT-60, Tel-Test, Inc, Friendswood, TX). RNA 
concentrations were determined spectrophotometrically and 1 µg of total RNA 
was reverse transcribed using a kit (Quanta Biosciences, Beverly, MA). Real-
time qRT-PCR was performed using a Quant Studio 3 real time PCR system 
(Thermo Fisher Scientific, Grand Island, NY).  
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The hepatic mRNA expression of select genes was detected by qRT-PCR, 
which is routine for the Beier laboratory. Primers and probes for Cpt1a1, Dgat2, 
Gsk3β, Pparα, Pck1, G6pase, Pgc1α, Sirt1, Atf4, Chop, Hsp90, Tfam, Fis1, 
Drp1, and Cox4 were ordered as commercially available kits (Thermo Fisher 
Scientific, Grand Island, NY). The comparative CT method was used to 
determine fold changes in mRNA expression compared to an endogenous 
reference gene (18S). This method determines the amount of target gene 
normalized to an endogenous reference and relative to a calibrator (2ΔΔCT).  
G. Immunoblots 
Liver samples were homogenized in RIPA buffer, containing protease and 
phosphatase inhibitor cocktails (Sigma-Aldrich, St. Louis, MO). Protein was 
quantified by Lowry assay using bovine serum albumin as a positive control. 
Liver homogenates or mitochondrial protein isolates (2.5 µg/µL, 1 µg/µL 
respectively) were loaded on to Bolt™ 4-12% Bis-Tris Plus gels (Invitrogen, 
Carlsbad, CA), followed by electrophoresis and Western blotting onto PVDF 
membranes (Immobilon-P, Millipore, Billerica, MA). Primary antibodies against 
GAPDH (1:2,000; Santa Cruz Biotechnology, Dallas, TX), cleaved caspase-3, 
pro-caspase-3, cytochrome c, phospho-Stat3S727, phospho-Stat3Y705, total 
Stat3, IP3-R1 (1:1,000; Cell Signaling Technologies, Danvers, MA), Chop 
(1:1,000; Thermo Scientific, Waltham, MA), and OXPHOS antibody cocktail 
(1:500, Abcam, Cambridge, MA) were used. Blots were developed onto blue 
sensitive autoradiography film (MidSci, St. Louis, MO) using SuperSignal West 
Dura Extended Duration Substrate (Thermo Scientific, Rockford, IL). 
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Densitometric analysis was performed using UN-SCAN-IT gel software (Silk 
Scientific Inc., Orem, UT).  
H. Electron Microscopy (EM) 
EM analysis was performed as previously described (58). Briefly, liver tissues 
were fixed with 2.5% glutaraldehyde in 0.1 mol/L phosphate buffer (pH 
7.4), followed by 1% OsO4. After dehydration, thin sections were stained with 
uranyl acetate and lead citrate for observation under a JEM 1011CX electron 
microscope (JEOL). Images were acquired digitally. 
I. Statistical analyses 
Power analysis was used to calculate the number of animals required for the 
experiments. Results are reported as means ± standard error (SEM, n=4-12) and 
were analyzed using SigmaPlot 11.0 (Systat Software, Inc., San Jose, CA). 
Unless otherwise specified, one-way or two-way ANOVA with Bonferroni’s post-
hoc test (for parametric data) or Mann-Whitney Rank Sum test (for 
nonparametric data) were used for determination of statistical significance among 
treatment groups, as appropriate. A p value less than 0.05 was selected before 





CHAPTER III  
  
VINYL CHLORIDE ENHANCES DIET-INDUCED LIVER INJURY IN MICE 
  
A. Introduction  
Vinyl chloride (VC) is a volatile organic compound and organochlorine 
toxicant. VC is known to cause direct hepatic damage at high, occupational 
exposures (34). As mentioned in Chapter I, OSHA enforced stricter exposure 
guidelines for occupational VC exposure in 1975. Although this prevents acute 
exposure in the industrial setting, there are still opportunities for chronic, low-
level exposure via environmental contamination and exposure. VC is ranked #4 
on the CDC’s Agency for Toxic Substances and Disease Registry (ATSDR) 
Substance Priority List (59). This list ranks chemicals based on not only toxic 
potency, but also human risk for exposure. Clearly, due to its top five ranking, VC 
remains a relevant toxicant when evaluating human environmental pollutant risk. 
VC is ubiquitous at many EPA designated Superfund sites across the United 
States, as both a direct contaminant and as a degradation product of 
trichloroethylene (TCE) and perchloroethylene (PCE) (60). Many of these 
Superfund sites are in close proximity to residential areas, causing concern for 
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exposure. Additionally, factories that produce polyvinyl chloride (PVC) plastic 
products utilize VC monomer and also emit VC gas as a waste product into the 
environment. Residential areas surrounding both manufacturing and Superfund 
sites are susceptible to VC migrating through soil into home foundations where it 
readily volatilizes to enter showers, basements, and living spaces in which these 
vapors recirculate and are inhaled (61;62).Therefore, understanding the effects 
of VC toxicity on human health is imperative.  
The obesity epidemic is a prevalent and concerning health issue in the 
United States with over 1/3 (35.6%) of the adult population considered obese 
(BMI > 30 mg/km2) (39). Indeed, in a recent analysis by Flegal et al., current 
trends depict that obesity rates are still rising and are predicting to continue to 
rise in the coming years (63). Previous studies in the Beier laboratory have 
demonstrated enhanced liver injury in mice with exposure to HFD and CE, a VC 
metabolite. There are several pathologies associated with obesity including 
cardiovascular disease, metabolic syndrome, and type 2 diabetes. The major 
hepatic manifestation of metabolic syndrome is non-alcoholic fatty liver disease 
(NAFLD). It is now well-known that underlying liver injury, such as NAFLD, can 
influence progression and severity of liver disease development. Due to the fact 
that the average BMI of the American population has increased dramatically 
since the OSHA regulation was implemented (37), it is crucial to re-evaluate the 
impact of low-level VC exposure in the context of underlying liver injury. 
VC concentrations below the current OSHA limit are relevant not only for 
industrial workers, but also for environmental exposures for residents living in 
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proximity to both Superfund and PVC-manufacturing facilities. Therefore, the 
goal of this aim was to develop an animal model relevant to human VC exposure 
to more closely mimic liver injury and risk for disease progression observed. 
B. Experimental Procedures 
1. Animals and treatments  
6 week old, male C57Bl/6J mice were exposed to sub-OSHA 
concentrations of VC via inhalation or room air for 6 hours per day, 5 days per 
week, for up to 12 weeks as described in Chapter II, Section A.1. Mice were fed 
either a low fat diet (LFD) or high fat diet (HFD) as detailed in Chapter II, Section 
A.4. Upon sacrifice, tissues were collected as described in Chapter II, Section 
A.2.  
2. Metabolic phenotype 
Metabolic phenotype was described via metabolic cage analyses, 
DEXAscan analysis, and monitoring of body weight and food consumption was 
done as described in Chapter II, Section A.5. 
3. Biochemical analyses 
Plasma transaminase levels were analyzed as described in Chapter II, 
Section C.1. Plasma protein levels of inflammatory cytokines were analyzed as 




To quantify thrombin-anti thrombin (TAT) complexes in all experimental groups, a 
TAT ELISA was performed as described in Chapter II, Section C.3.  
5. Histology  
Liver sections were stained with hematoxylin and eosin for general 
morphology as described in Chapter II, Section B.1. Visualization of neutrophils 
and macrophages was achieved by CAE and F4/80 staining as described in 
Chapter II, Section B.2, B.4. Apoptosis was detected via TUNEL staining as 
described in Chapter II, Section B.6. Detection of fibrin via immunofluorescence 
was performed as described in Chapter II, Section B.5. 
6. Immunoblots 
Whole liver lysates were examined via Western blot for cleaved caspase-
3, pro-caspase-3, and GAPDH, and mitochondrial lysates were examined for 
cytochrome C via Western blot as described in Chapter II, Section G.  
7. Statistical analyses 
Results are reported as means ± standard error (SEM, n=4-12) and were 
analyzed using SigmaPlot 11.0 (Systat Software, Inc., San Jose, CA). Unless 
otherwise specified, one-way or two-way ANOVA with Bonferroni’s post-hoc test 
(for parametric data) or Mann-Whitney Rank Sum test (for nonparametric data) 
were used for determination of statistical significance among treatment groups, 
as appropriate. A p value less than 0.05 was selected before the study as the 
level of significance. a, p<0.05 compared to the absence of HFD; b, p<0.05 




1. Vinyl chloride does not alter diet-induced body mass 
composition  
To assess animal condition and whole animal metabolism in this model, 
body weight and food consumption were measured weekly. Figure 3.1A shows 
body weight gain for the 12-week experiment for all groups. Animals exposed to 
LFD + VC did not gain more body weight compared to LFD controls. Although 
there was a diet effect on body weight with HFD, the addition of VC did not 
significantly enhance this effect. Body mass composition analysis at the 12 week 
time point revealed that there were no significant alterations in either lean or fat 
mass distribution with VC exposure (Figure 3.1B). Independent of diet or VC 
exposure, food consumption did not change between groups across the 12-week 
experiment (Figure 3.1A). Liver to body weight ratios were similar for LFD ± VC 
animals. HFD significantly increased liver to body weight ratios at both 8 and 12 
weeks. However, VC did not further enhance this effect (Figure 3.1A).  
In order to evaluate systemic metabolism, mice were placed in metabolic 
chambers for 12 hours in which food and water intake, oxygen consumption 
(VO2), carbon dioxide production (VCO2), and physical activity measurements for 
individual mice were obtained. Food and water intake were similar in both HFD 
and HFD + VC treated animals at 12 weeks of exposure (Figure 3.1C). However, 
VC significantly decreased VO2 and VCO2 values (Figure 3.1C). Interestingly, the 
respiratory exchange ratio (RER) did not change compared to HFD control 

















Figure 3.1. VC does not alter body mass composition.  A: Body weights were 
measured once per week and are depicted for the 12-week exposure period. 
Food consumption was measured twice/week for the 12-week exposure period. 
Liver weight to body weight ratios were calculated for each group for each time-
point. B: DEXAscan analysis was performed for all treatment groups at the 12-
week time point. Representative photos are shown. Body mass is graphed as 
body fat in percent of total tissue, lean body mass and fat mass in grams. C: 
Representative parameters of metabolic function are depicted for mice exposed 
to HFD ± VC. a, p<0.05 compared to LFD or HFD control. 
  


































































































































































































































































































































dioxide production and no shift in macromolecule source for energy expenditure. 
While a decrease of RER may be caused by a decrease in physical activity, VC 
did not alter physical activity levels (assessed by fine movement, ambulatory 
counts, and total beam breaks) of the mice (Figure 3.2C).  
2. Vinyl chloride enhances HFD-induced liver injury 
Recently, the Beier laboratory has demonstrated enhanced liver injury with 
exposure to a VC metabolite (chloroethanol, CE), and HFD feeding (27). Here, 
using a more relevant model of VC exposure, histological and biochemical 
indices of liver damage were assessed. Figure 3.2A depicts representative 
photomicrographs of liver sections stained with hematoxylin and eosin (H&E) for 
visualization of general liver morphology and fibrin staining as an index of local 
tissue injury. Normal morphology and transaminase activity were observed in 
LFD control animals, and no overt pathologic changes were observed in animals 
exposed to LFD + VC, nor did they display increases in transaminase activity 
(Figure 3.2A, B). HFD feeding increased both steatosis, as evidenced by the 
H&E stain, and fibrin accumulation (Figure 3.2A). Interestingly, VC significantly 
enhanced indices of damage observed including fibrin accumulation and 
transaminase activity in mice fed a HFD (Figure 3.2A, B). In order to determine 
the mechanism of enhanced fibrin deposition in the HFD + VC group, plasma 
PAI-1 and TAT levels were analyzed (Figure 3.2C). Fibrin accumulation can 









Figure 3.2. VC enhanced diet-induced liver injury. A: Representative 
photomicrographs of H&E (general morphology, 200x) and plasma transaminase 
(ALT/AST) levels were determined for the 12-week time point. B: Representative 
photomicrographs for fibrin immunofluorescence (200x). C: Image analysis for 
fibrin is graphed as relative fluorescence units (RFU) as percent of microscope 
field and plasma thrombin-antithrombin (TAT) and protein concentrations of PAI-1 
are shown in µg/L and pg/L, respectively. a, p<0.05 compared to LFD control; b, 
p<0.05 compared to absence of VC. 
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through inhibition of fibrin degradation via PAI-1 activity. Here, VC exposure had 
no effect on either TAT or PAI-1 levels in the absence of HFD feeding. 
Interestingly, while PAI-1 levels increased in a diet-dependent manner, TAT 
levels were significantly increased in the HFD + VC group, while PAI-1 levels 
remained unchanged. These data suggest that fibrin accumulation in this model 
is due to altered coagulation rather than changes in PAI-1 expression.  
3. VC enhanced diet-induced neutrophil infiltration 
VC enhanced HFD-induced liver injury observed in this model, therefore 
indices of liver inflammation were assessed to determine if hepatic inflammation 
is involved in the mechanism of VC-induced damage. Here, histologic markers of 
neutrophil infiltration (CAE staining), and macrophages (F4/80 
immunohistochemistry), were examined for the 12 week time point (Figure 3.3A, 
B). There were no differences in either neutrophil or macrophage recruitment in 
animals exposed to LFD ± VC. HFD control animals had significantly more 
infiltrating neutrophils than their LFD counterparts, however no changes were 
observed in macrophage recruitment. VC significantly enhanced neutrophil 
accumulation, indicating more hepatic inflammation and injury compared to HFD 
control animals. Similar to the HFD group, VC also caused no alterations in 
macrophage recruitment. Plasma protein concentrations of inflammatory 
cytokines were also examined (Figure 3.3C). While HFD significantly elevated 
plasma protein concentrations of MCP-1, this effect was not altered by VC. 











Figure 3.3. VC enhanced diet-induced neutrophil infiltration. A: 
Representative photomicrographs of CAE (neutrophils, 200x) are shown and 
CAE-positive cells were counted and graphed as positive cells per 1000 
hepatocytes. B: Representative photomicrographs of F4/80 (macrophages, 200x) 
IHC is shown for the 12-week time-point and image analysis for F4/80 is graphed 
as positive staining as percent of microscope field. C: Plasma protein 
concentrations of MCP-1, IL-6, and TNFα are shown in pg/mL. a, p<0.05 









































































































































4. Vinyl chloride causes increased NPC apoptosis, but not 
hepatocyte apoptosis  
The mechanism of cell death and cell type specificity is often imperative 
for determining the mechanism of injury and pathways involved in cellular 
damage. For example, apoptotic hepatocyte death is characteristic of NAFLD 
pathogenesis and this effect has been well characterized (64;65). In this study, in 
order to better understand the increased liver injury and inflammation observed, 
cell death pathways were investigated. Cleaved caspase-3 protein levels were 
analyzed via Western blot for whole liver lysates at the 12 week time point 
(Figure 3.4A). No differences were observed for LFD + VC animals compared to 
LFD controls. HFD significantly increased the amount of cleaved capase-3 
protein levels. Interestingly, HFD + VC had significantly enhanced levels of 
cleaved caspase-3, indicating enhanced activation of the apoptotic pathway. 
Additionally, mitochondrial protein isolates from the same treatment groups at 6 
weeks of exposure were analyzed for cytochrome c via Western blot (Figure 
3.4B). Cytochrome c release from mitochondria is known to be involved in the 
activation of apoptotic signaling cascades (66). Here, a significant VC effect 
observed. Independent of diet, VC significantly decreased cytochrome c levels 
within mitochondria, indicating an increased release into the cytosol, which 
suggests activation of apoptosis.  
However, for a more cell-specific analysis of apoptosis and to determine 
the levels of apoptosis occurring, TUNEL staining was performed for the 12 week 
time point. Representative photomicrographs of TUNEL stained liver section
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Figure 3.4. Effect of VC on apoptotic signaling. A: Representative Western 
blots for whole liver Caspase-3 protein are shown. B: Representative Western 
blots for hepatic mitochondrial Cytochrome c protein are shown. C: The 
corresponding densitometric analyses are shown for both Caspase-3 and 
Cytochrome c are shown as fold of control. a, p<0.05 compared to LFD control; b, 






























































































and the corresponding TUNEL-positive cell counts (hepatocytes and NPCs) are 
shown in Figure 3.5A,B. Animals exposed to LFD ± VC did not exhibit changes in 
the number of TUNEL-positive cells. Interestingly, HFD feeding did not change 
the number of apoptotic hepatocytes or NPCs. VC did not change this effect in 




















Figure 3.5. VC did not cause hepatocyte apoptosis, but increased NPC 
apoptosis. A: Representative photomicrographs for TUNEL staining are shown 
(200x). B: TUNEL-positive hepatocytes and NPCs were counted and TUNEL-
positive cells per 1000 hepatocytes are depicted. a, p<0.05 compared to LFD 
control; b, p<0.05 compared to absence of VC. 
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D. Discussion  
As mentioned in the Introduction, VC exposure at high levels is known to 
directly cause malignant and nonmalignant liver disease. OSHA enforced stricter 
VC exposure guidelines in the occupational setting after a series of severe and 
rare liver angiosarcomas diagnoses occurred at a VC production facility during 
the 1970’s. The new exposure thresholds significantly reduced the risk of acute 
exposures to high concentrations of VC. However, more recently, the field of 
environmental toxicology has begun to shift to an ‘exposure biology’ paradigm. 
Exposure biology focuses on the impact of moderate/low level, chronic 
exposures in contrast to high, occupational exposures. The risk for low-level, 
chronic VC exposure remains a concern both for workers and for residential 
populations living in close proximity to industrial and Superfund sites. 
Furthermore, the majority of experimental studies with VC have used extremely 
high concentrations (>100 ppm) and focused mainly on its carcinogenic effects 
(23;24). Therefore, the potential impact of lower, chronic exposure remains 
unknown. The major goal of this study was to develop and characterize a mouse 
model of chronic, sub-OSHA VC exposure in order to fill the gaps in our 
understanding regarding the impact of VC exposure at low concentrations.  
Exposure biology also acknowledges that underlying disorders and 
sensitivities may act to modify risk for developing more severe disease 
phenotypes and as such should be a critical consideration. The pandemic of 
obesity is quite possibly the most prevalent underlying liver disorder that impacts 
the American population. More than 2/3 of the United States is at risk for 
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developing obesity-associated NAFLD, the hepatic manifestation of metabolic 
syndrome. Several studies have identified potential interactions between 
environmental chemical exposures and experimental NAFLD (67-70). Although 
the mechanisms by which this occurs are incompletely understood, most of these 
environmental chemicals enhance pathologic responses (e.g., inflammation) and 
act to sensitize hepatocytes to injury. Due to the fact that the American average 
BMI has increased dramatically since the VC safety thresholds were initially set 
(37), a second major goal of this study was to determine the impact of VC 
exposure on liver injury caused by a HFD. The data presented here demonstrate 
that sub-OSHA levels of VC exposure are sufficient to enhance liver injury 
caused by a HFD. This raises concerns regarding the current OSHA regulations 
in place. These results are in line with previous epidemiological studies with VC 
exposure and comorbidities. For example, Mastrangelo et al. showed that VC 
workers were at greater risk for developing alcoholic liver disease (71).  
First, the effects of VC exposure on overall hepatic inflammation and 
damage were determined for 12 weeks of exposure. Here, VC exposure alone 
did not cause any overt toxicity or liver damage in animals fed control diet. 
(Figure 3.2). Additionally, VC did not affect body weight gain, food consumption, 
adiposity, or indices of liver injury (liver weight, transaminase levels, and 
histology) for the LFD group. The combination of HFD feeding and VC exposure 
significantly enhanced indices of liver damage as assessed by histology and 
transaminase levels. Interestingly, although VC exacerbated HFD-induced 
neutrophil recruitment to the liver (Figure 3.3) it did not affect macrophage 
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recruitment or cytokine levels (Figure 3.3). This effect can be partially explained 
by the observed increase in NPC apoptosis with the combination of HFD and VC 
exposure (Figure 3.5). 
Neutrophils are acute responders to local injury as part of the innate 
immune response (72). Additionally, neutrophil accumulation within liver tissue is 
a hallmark of NAFLD pathogenesis (73). In accordance with the literature, here, 
HFD feeding caused significant neutrophil recruitment to the liver. Interestingly, 
enhancement of this effect was observed with HFD feeding and VC exposure in 
this model, suggesting enhanced local tissue injury or alterations in the hepatic 
extracellular matrix (ECM), specifically fibrin accumulation (Figure 3.2). Indeed, 
the combination of HFD and VC caused significant hepatic fibrin accumulation. 
Fibrin has been shown to facilitate both neutrophil chemotaxis and activation 
(74). However, neutrophils have also been shown to be critically involved in the 
breakdown of fibrin ECM. Fibrin ECM accumulation can occur via two pathways; 
increased deposition or impaired generation (75). A major inhibitor of fibrin 
degradation is PAI-1. Notably here, although PAI-1 protein levels increased with 
HFD, this effect was not enhanced by VC. This suggests that the fibrin 
accumulation observed is due to enhanced deposition via coagulation rather than 
impaired degradation by PAI-1. Upon further analysis, plasma thrombin anti-
thrombin levels were found to be significantly increased with HFD and VC 
exposure, suggesting that de novo fibrin deposition by the coagulation cascade 
contributes to the local hepatic damage observed under these conditions.   
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 Cave et al. previously showed that occupational VC exposure increased 
total plasma cytokeratin 18 in humans, but not the caspase-cleaved isoform (34); 
suggesting an increase in necrosis rather than apoptosis in the liver (76). Indeed, 
similar results were observed here; although the increase in hepatic caspase-3 
cleavage caused by HFD was significantly enhanced by the addition of VC 
exposure, the number of TUNEL-positive hepatocytes did not change. This 
suggests that apoptosis does not play a major role in hepatocyte cell death in this 
model. In contrast, the number of TUNEL-positive NPCs, such as Kupffer cells, 
significantly increased with the combination of HFD and VC. This significant 
increase in NPC death could also explain the decrease plasma MCP-1 protein 
levels with HFD and VC, as Kupffer cells and other cells are able to secrete 
MCP-1 for recruitment of monocytes to aid in tissue repair (77), and a decrease 
in their population would result in a lower levels observed in circulation.  
Taken together, the results from this study show that sub-OSHA levels of 
VC exposure are sufficient to exacerbate experimental NAFLD. Although 12 
weeks of VC exposure alone does not cause overt livery injury or toxicity, it did 
cause the liver to be more susceptible to diet-induced damage. Indeed, 
increased indices of tissue injury, liver damage, and neutrophil recruitment were 
all observed with the combination of HFD feeding and VC exposure. This study 
reinforces the need to better mimic human exposure, taking into account multiple 
factors when evaluating liver disease and pathology. This study also supports the 
need for further investigation into low-level toxicant exposure and its effect and 





CHAPTER IV  
  
VINYL CHLORIDE DYSREGULATES HEPATIC GLUCOSE METABOLISM 
 AND ENHANCES OXIDATIVE AND ENDOPLASMIC RETICULUM STRESS  
  
A. Introduction  
Vinyl chloride (VC) is a known hepatotoxicant and carcinogen at high 
exposure levels. The majority of its damaging effects are attributable to the 
reactive metabolites that are formed upon VC metabolism by the liver. VC 
metabolism occurs strikingly similar to that of ethanol with the majority of its 
reactive intermediates being produced by and within hepatocytes themselves. 
Therefore it is likely that VC may act by many of the same mechanisms to both 
cause and enhance injury. It is important to consider that the liver may be 
uniquely susceptible to metabolic disruption and endogenous stress caused by 
VC exposure. In VC workers exposed to high concentrations, hepatic steatosis or 
fat accumulation is known to occur. Hsiao et al. performed an ultrasound study of 
PVC facility workers that were asymptomatic for liver disease. Intriguingly, 38.9% 
of the workers analyzed presented with hepatic steatosis even though they had a 
normal mean body mass index (78). This suggests that occupational exposures 
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to VC are sufficient to alter hepatic lipid metabolism. More recently, Guardiola et 
al., determined significant changes in the metabolome of highly exposed VC 
workers who did not develop cancer (79). This work identified alterations in key 
pathways that regulate energy homeostasis including the AMP-activated protein 
kinase (AMPK) and Protein kinase B (AKT) signaling pathways. Additionally, 
Anders et al., observed similar metabolic changes with the administration of a 
single dose of chloroethanol, CE, in a mouse model (26). The concomitant 
activation of both mTOR and AMPK, which are typically activated in opposition of 
one another was observed, indicating dysregulated energy metabolism. 
Supporting the changes in phosphorylation observed, were histological changes 
as well. Increased hepatic lipid accumulation accompanied by depleted glycogen 
suggest altered energy homeostasis in that model.  
Importantly, metabolic stress can act in concert with other stressors to cause 
enhanced cellular damage and potentially cell death. Both oxidative and 
endoplasmic reticulum (ER) stress are known contributors to NAFLD 
pathogenesis (80,81,82). Indeed, the VC metabolite 2-chloroethylene oxide is 
known to cause oxidative DNA damage (12) and its reactive aldehyde species, 
chloroacetaldehyde (CAA) has been shown to cause protein adducts (26). 
The purpose of this study was, therefore, to examine metabolic homeostasis 
at both early and later time points of low-level VC exposure both alone and in 
combination with a HFD to determine if disruption in nutrient homeostasis plays a 
role in VC-induced liver injury. Additionally, this study also sought to provide 
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mechanistic insight into the roles of ER stress and oxidative stress activation, as 
they are known pathogenic regulators of NAFLD progression. 
Experimental Procedures  
1. Animals and treatments 
6 week old, male C57Bl/6J mice were exposed to sub-OSHA levels of VC 
for 6 hours per day, 5 days per week as described in Chapter II, Section A.1, and 
fed either a low fat diet (LFD) or high fat diet (HFD) as described in Chapter II, 
Section A.4. Animals were sacrificed at 6 and 12 weeks of exposure and blood 
and tissue were collected as specified in Chapter II, Section A.2. Whole animal 
glucose homeostasis was evaluated by OGTT, PTT, and ITT at 6 weeks of 
exposure as described in Chapter II, Section A.5. 
2. Biochemical analyses  
Hepatic lipids were extracted from snap frozen liver tissue as described in 
Chapter II, Section C.1 and levels of triglycerides, free fatty acids, and 
cholesterol were determined as described in Chapter II, Section C.1. Hepatic 
TBARS concentrations were measured as detailed in Chapter II, Section C.1. 
3. Histology and electron microscopy 
Histology for neutral lipids and glycogen accumulation was performed as 
described in Chapter II, Section B.7 and image analysis was performed as 
described in Chapter II, Section B.8. Immunohistochemistry for lipid peroxidation 
adducts (4-HNE and MDA) were performed as described in Chapter II, Section 
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B.3. Tissue processing and visualization via electron microscopy was performed 
as explained in Chapter II, Section H.  
4. Immunoblots 
Whole liver lysates were analyzed via Western blot for CHOP as 
described in Chapter II, Section G.  
5. RNA and real-time RT-PCR  
Hepatic mRNA was isolated from fresh tissue and converted to cDNA as 
described in Chapter II, Section F. Hepatic mRNA expression was then 
measured via real-time qRT-PCR as explained in Chapter II, Section F.  
6. Statistical analyses  
Results are reported as means ± standard error (SEM, n=4-12) and were 
analyzed using SigmaPlot 11.0 (Systat Software, Inc., San Jose, CA). Unless 
otherwise specified, one-way or two-way ANOVA with Bonferroni’s post-hoc test 
(for parametric data) or Mann-Whitney Rank Sum test (for nonparametric data) 
were used for determination of statistical significance among treatment groups, 
as appropriate. A p value less than 0.05 was selected before the study as the 
level of significance. a, p<0.05 compared to the absence of HFD; b, p<0.05 




B. Results  
1. Vinyl chloride causes enhanced steatosis in high fat diet-fed 
animals 
Hepatic fat accumulation is a characteristic sign of liver disease and is 
typically the first pathological response to damage. In order to determine 
steatosis and assess lipid accumulation in this model, Oil Red-O (ORO) staining 
for neutral lipids (Figure 4.1A) and hepatic lipid analysis (Figure 4.1B) were 
performed for the 12 week time point. VC did not cause steatosis or alter hepatic 
lipid accumulation for triglycerides (TG), cholesterol (Chol), or free fatty acids 
(FFA) in the absence of HFD. HFD feeding significantly increased the amount of 
ORO positive staining compared to LFD control animals. Additionally, HFD 
animals had increased concentrations of hepatic TG, Chol, and FFA. HFD + VC 
exposed animals had significantly enhanced indices of macrovesicular steatosis 
such as increased ORO positive staining and TG levels. However, VC did not 
further increase the indices of microvesicular steatosis as shown by cholesterol 
and FFA concentrations. However, intriguingly, upon mRNA expression analysis 
of several genes involved in lipid metabolism, no alterations were observed for 








Figure 4.1. VC increased diet-induced steatosis. A: Representative 
photomicrographs of ORO (neutral lipids, 200x) are shown for the 12 week time 
point. B: Image analysis of ORO positive staining was performed and results are 
shown as percent of microscope field. Triglyceride (TG), cholesterol (Chol), and 
free fatty acid (FFA) levels were measured in hepatic lipid extracts for the 12 















































































































Figure 4.2. VC did not alter mRNA expression of metabolic genes. Hepatic 
mRNA expression of Cpt1a1, Dgat2, Gsk3β, and Pparα are represented as fold 































































































2. Vinyl chloride exposure is sufficient to alter hepatic glucose 
metabolism 
The Beier laboratory has established that exposure to VC metabolites 
dysregulate carbohydrate metabolism in the absence of a secondary stimulus 
(26). Therefore, in this model, indices of both liver specific and whole-body 
glucose metabolism were analyzed. Hepatic glycogen deposition was assessed 
by Periodic Acid Schiff (PAS) staining at 12 weeks of exposure (Figure 4.3A). 
LFD control animals show typical glycogen levels. Interestingly, LFD + VC 
significantly decreased hepatic glycogen accumulation. A similar trend was 
observed for HFD ± VC. In order to further determine a mechanism for this 
decrease in glycogen, mRNA expression of several gluconeogenic regulators 
were examined at an earlier time point (6 weeks exposure, Figure 4.3B).  
Phosphoenolpyruvate carboxykinase (Pck1), Glucose-6-phosphotase 
(G6Pase), and Peroxisome proliferator –activated receptor gamma coactivator 1-
alpha (Pgc1α) are all critical genes involved in glucose homeostasis. G6Pase 
catalyzes the reaction that allows glucose to be exported into systemic circulation 
while PCK1 is responsible for the first committed step of gluconeogenesis, and it 
therefore crucial for glucose homeostasis (Scheme 4.1). PGC1α is a known 
positive regulator of gluconeogenesis (83). Notably, VC exposure increased both 
Pck1 and G6Pase mRNA expression. Additionally, in line with the increased 
Pck1 expression, VC significantly increased Pgc1α expression compared to LFD 


















Figure 4.3. VC altered hepatic glucose metabolism. A: Representative 
photomicrographs for PAS staining are shown for the 12-week time-point 
(glycogen, 200x). B: Image analysis of PAS positive staining was performed and 
results are shown as percent of microscope field. Hepatic mRNA expression of 
Pck1, G6Pase, and Pgc1α are shown as fold change compared to LFD control 
animals at the 6-week time-point. a, p<0.05 compared to LFD control; b, p<0.05 











































































































































Scheme 4.1. Hepatic glucose metabolism. Changes in glucose metabolism 
are represented. Red denotes increased expression or abundance with VC, while 
green denotes decrease in product levels. Increased expression of glucose-6-
phosphotase (G6Pase) and phosphoenolpyruvate kinase (Pck1) are observed in 


















for LFD ± VC exposed animals, no significant effect was observed for HFD ± VC 
exposed animals.  
Whole-animal glucose homeostasis was analyzed through oral glucose, 
insulin, and pyruvate tolerance tests at both 6 and 11 weeks of exposure in order 
to assess systemic glucose metabolism. Although no significant VC effect was 
observed at the later time point, differences were seen at 6 weeks (Figure 4.4A). 
LFD + VC animals did not differ in comparison to LFD control animals in either 
the OGTT or ITT analyses. However, VC significantly increased glucose levels 
during the PTT, indicating increased gluconeogenic activity. As expected, HFD 
significantly decreased glucose tolerance with higher blood glucose levels 
compared to LFD controls and VC enhanced this effect at the 15 minute time 
point, indicating more severe glucose intolerance. Additionally, plasma protein 
levels of several adipokines were analyzed via Luminex (Figure 4.3B) at 6 weeks 
of exposure. Interestingly, although differences in glucose tolerance were 
observed at 6 weeks of exposure, no alterations were observed for any of the 
adipokines examined. However, at 10 weeks of exposure, there are significant 
differences among the experimental groups. HFD significantly increases leptin 
and resistin levels compared to LFD controls, however, VC does not enhance 
this effect. Intriguingly, LFD + VC exposed animals have significantly increased 
















Figure 4.4. VC altered whole-animal glucose homeostasis. A: OGTT, ITT, 
and PTT were performed at 6 weeks of exposure. B: Plasma protein 
concentrations of adipokines leptin, insulin, and resistin were determined for the 
6 week time point and are represented as pg/mL. C: OGTT was performed at 10 
weeks of exposure and plasma protein concentrations of leptin, insulin, and 
resistin were measured at 12 weeks of exposure and are expressed in pg/mL. a, 






















































































































































































3. Vinyl chloride enhances NAFLD-induced oxidative stress 
Oxidative stress plays a critical role in propagating inflammatory and 
stress responses in multiple disease states and it results from an imbalance of 
reactive oxygen and reactive nitrogen species (ROS/RNS) and the antioxidant 
capacity of the cell (84). Oxidative stress is also a known component of NAFLD 
pathology (85). Additionally, oxidative damage can occur upon covalent adduct 
formation on major macromolecules such as DNA, lipids, and proteins. 
Importantly, chloroacetaldehyde has been shown to cause lipid oxidation adducts 
in vivo (26). Here, several lipid peroxidation adduct products were examined 
immunohistochemically via 4-hydroxynonenal (4-HNE) and malondialdehyde 
(MDA) staining (Figure 4.5A,B). LFD control animals show typical positive 
staining for both 4-HNE and MDA staining, as some endogenous oxidative stress 
is present. Interestingly, LFD + VC exposed animals have significantly more 
positive 4-HNE staining than LFD controls (Figure 4.4A). As expected, HFD 
feeding increased both 4-HNE and MDA positive staining. VC significantly 
enhanced both 4-HNE and MDA positive staining compared to HFD control 
animals, suggesting an enhanced oxidative stress response.  
To further evaluate the role of oxidative damage in this model, hepatic 
levels of TBARS were analyzed from liver tissue (Figure 4.5B). No differences 
were observed in LFD ± VC animals. HFD significantly increased the amount of 







Figure 4.5. Vinyl chloride enhances NAFLD-induced oxidative stress. A: 
Representative photomicrographs for 4-HNE (oxidative stress, 200x), and MDA 
(oxidative stress, 200x), are shown at 12 weeks. B: Image analysis for 4-HNE 
and MDA are graphed as positive staining as percent of microscope field and 
hepatic TBARS concentration were measured and normalized to protein 
concentration. a, p<0.05 compared to LFD control; b, p<0.05 compared to 
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4. Vinyl chloride caused endoplasmic reticulum (ER) stress  
The Beier laboratory has identified that ER stress is significantly enhanced by 
VC metabolite exposure both in vitro and in vivo. The ER plays a major role in 
managing intracellular protein homeostasis and its stress activation can cause 
initiation of inflammatory and apoptotic pathways. Here, several indices for ER 
stress activation were examined for the 12 week time point. Figure 4.6 depicts 
transmission electron microscopy images for each of the treatment groups. Both 
LFD and HFD control animals show normal ER morphology, with tight folds 
indicative of proper function. Notably, LFD + VC and HFD + VC animals show 
dilation of the ER lumen, which is indicative of ER stress and an accumulation of 
misfolded or adducted proteins. As part of the ER membrane, the nuclear 
membrane was also dilated in these groups, morphologically indicating the 
activation of the UPR.  
Hepatic mRNA expression of several ER stress markers were analyzed for 
the HFD and HFD + VC experimental groups. Sirtuin 1 has recently been 
identified as a negative regulator of ER stress (86). Indeed, here VC significantly 
decreased Sirt1 expression compared to HFD controls (Figure 4.7A). 
Additionally, Activating transcription factor 4 (Atf4), CCAT-enhancer-binding 
protein homologous protein (Chop), and Heat shock protein 90 (Hsp90) mRNA 
expression were examined as markers of ER stress activation. HFD + VC 
significantly increased expression of all these indices examined. Protein levels of 
CHOP were analyzed for all experimental groups (Figure 4.7B). VC did not 
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change relative CHOP levels in the LFD group. Although HFD increased CHOP 











Figure 4.6. VC increased ER dilation independent of diet. Representative EM 
photomicrographs are shown for all experimental groups at 12 weeks of 
exposure. Arrows denote dilated ER, including the nuclear membrane as part of 
the ER membrane. LD = lipid droplet, ER = endoplasmic reticulum, Mito = 




























Figure 4.7. VC increased ER stress markers. A: Hepatic mRNA expression of 
ER stress markers Sirt1, Atf4, Chop, and Hsp90 are shown for HFD and HFD + 
VC at 12 weeks of exposure and are expressed as fold of control compared to 
HFD control animals. B: Representative Western blot and densitometric analysis 
of CHOP are shown. a, p<0.05 compared to HFD control. 
  























































































C. Discussion  
As stated in the Introduction, it is known that acute, occupational exposures to 
VC directly cause hepatic injury and TASH-associated pathologies (34). 
Additionally, people exposed to VOC (including VC) contaminated drinking water 
at the Camp Lejeune military base in North Carolina during the 1980’s are still 
presenting with health complications, including liver disease, to this day (87). 
Therefore, it is imperative to understand the mechanisms by which VC acts to 
sensitize and injure hepatocytes, resulting in its associated malignant 
pathologies. Importantly, a hallmark of NAFLD is hepatic metabolic disruption 
and accumulation of lipids (88). Other mechanisms involved in the progression of 
NAFLD to NASH are oxidative and ER stress activation, which act to influence 
hepatocyte sensitivity and increase cellular injury (89;90). 
Several VOCs are known to disrupt lipid metabolism and insulin signaling, in 
addition to inducing oxidative and ER stress activation, which contributes to their 
toxicity. For example, acrolein has been shown to form protein adducts and 
subsequent ER and oxidative stress activation (91;92). Additionally, TCE 
metabolites have been shown to cause lipid peroxidation adducts in vivo which 
produce oxidative damage (93). Therefore, the goal of this study was to 
determine if VC exposure induced hepatic metabolic changes to increase 
hepatocyte susceptibility to damage.  
Here, VC exposure exacerbated HFD-induced macrovesicular steatosis and 
glycogen depletion at 12 weeks of exposure (Figure 4.1). It is known that 
accumulating lipids within hepatocytes can lead to lipotoxic effects (94-96). 
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Therefore, although no differences were observed between levels of hepatic free 
acids and cholesterol, it is probable that their accumulation is more susceptible to 
lipotoxic effects by becoming oxidized in the presence of VC exposure. 
Additionally, hepatocytes exposed to both HFD and VC may be more sensitive to 
these toxic lipid species and their ability to activate pro-apoptotic and stress 
pathways (97;98) which subsequently result in enhanced cellular injury.  
Although significant alterations in histology were observed at 12 weeks of 
exposure, no associated change in mRNA expression in metabolic genes was 
observed for this time point. Therefore, an earlier exposure time point of 6 weeks 
was selected to provide mechanistic insight into the histological changes 
observed. This aim also sought to build upon previous work, which suggests that 
VC alone is enough to alter hepatic metabolic processes. Indeed, this work 
demonstrates that VC alone alters hepatic glucose metabolism (6 weeks) prior to 
the observation of enhanced hepatic oxidative and ER stress at 12 weeks of 
exposure. Several key regulators of the gluconeogenic pathway had significantly 
increased hepatic mRNA expression with VC alone compared to LFD control 
animals. One such regulator is Pgc1α, a transcription factor that positively 
regulates gluconeogenesis (99). Here, independent of diet, a VC effect is 
observed with increased Pgc1α mRNA expression. This suggests that an 
adaptive response has been activated in order for the hepatocytes to maintain 
both glucose and cellular energy levels (100). VC exposure causes a depletion in 
glucose levels which prompts the hepatocytes to upregulate gluconeogenic 
pathways, simultaneously depleting glycogen reserves. Additional support for this 
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hypothesis can be found from the pyruvate tolerance test (PTT) data at 6 weeks 
of exposure (Figure 4.4). The PTT can be used as an index of gluconeogenic 
capacity by the administration of pyruvate, a substrate for glucose production and 
subsequently measuring blood glucose levels. Although no effect was observed 
for animals fed a HFD, a significant peak in glucose levels occurred in animals 
exposed to LFD and VC after pyruvate challenge compared to controls, 
physiologically indicating enhanced gluconeogenic flux. These data may aid in 
the explanation of the increased insulin level observed in LFD + VC exposed 
animals at 12 weeks of exposure. The increased capacity for glucose production 
acts to combat the energy needs of the cell, however, it also increases circulating 
glucose levels (101;102). This may consequently aid in developing insulin 
resistance as seen through the increased insulin and resistin levels.  
Oxidative and ER stress are often coupled events and part of a ‘vicious cycle’ 
hypothesized to propagate fatty liver diseases (103-105). Here, VC significantly 
enhanced the accumulation of lipid peroxidation products and oxidatively 
damage proteins caused by HFD feeding as seen by 4-HNE and MDA 
immunohistochemistry (Figure 4.5). Interestingly, LFD + VC exposed mice did 
show significantly more 4-HNE adducts when compared to LFD control animals. 
This indicates that VC is in fact sufficient to produce biomolecular damage 
without the addition of a secondary stimulus, however, with the addition of HFD, 
an enhanced effect is observed with increased accumulation over either factor 
alone. 4-HNE is an extremely toxic reactive aldehyde species with high 
intracellular levels causing irreversible biomolecule damage and cell death 
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(106;107). A diet effect was observed on levels of TBARS analyzed from hepatic 
tissue, although VC did not enhance this effect. However, TBARS is a notoriously 
non-specific assay due to MDA’s instability and high reactivity with proteins 
(108;109), however is still a major index used to quantify the oxidative adduct, 
MDA. Therefore, it is possible that the results observed reflect this trait. Further, 
the VC-enhanced oxidative adducts were accompanied by concomitant 
enhancement of UPR activation and ER stress. Indeed, increased expression of 
ER stress markers were observed with the combination of HFD and VC and, 
notably, ER dilation was observed morphologically via electron microscopy for 
both VC exposed experimental groups (Figure 4.6). These data suggest that VC-
induced metabolic dyshomeostasis plays a significant role in hepatocyte 
sensitization to further damage, such as oxidative stress. The metabolically 
damaged hepatocytes are unable to recover from oxidative damage and this 
incites the UPR and cell death pathways (Aim 1).  
Taken together, the data from this aim describe a possible mechanism by 
which VC exposure enhances liver injury. Sub-OSHA concentrations of VC 
exposure alone cause alterations in hepatic glucose metabolism, which then 
render the cells to be susceptible to injury from both chronic exposure to VC and 
additive damage caused by a HFD. This was observed by increases in lipid 
peroxidation products and ER stress responses. This study revealed a novel 









DETERMINING THE MECHANISM OF VINYL CHLORIDE INDUCED 
MITOCHONDRIAL DYSFUNCTION  
 
A. Introduction  
Mitochondria are essential for the function and health of all cell types. 
Mitochondria respond dynamically to changes in nutrient availability and a variety 
of stress signals. Their morphology and function varies depending on cell type 
and even can vary within the same cell (110). Mitochondrial dysfunction is 
involved in and also caused by many diseases. A hallmark of NAFLD 
pathogenesis is mitochondrial dysfunction (111). It is known that consuming a 
diet high in fat causes an abnormal increase in free fatty acids and triglycerides, 
affecting β-oxidation by mitochondria and impacting whole cell nutrient status. 
This abnormal influx of free fatty acids and triglycerides causes a metabolic shift 
within hepatocytes in which mitochondria increase their fatty acid oxidation (FAO) 
and oxidative phosphorylation (OXPHOS) capacities as a compensatory 
mechanism (112). Mitochondrial abnormalities have been demonstrated in 
human populations presenting with NASH as evidenced by altered mitochondrial 
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structure and decreased ATP production (113;114). Further, Einer et al., have 
recently shown that both mitochondrial morphology and function are altered by a 
high fat diet in a mouse model (115).  
Mitochondria are a significant source of endogenous ROS as electron leak 
occurs during normal oxidative respiration (116;117). However, as a 
consequence of mediating the altered nutrient flux, there is often an increase in 
mitochondrial electron leakage. In NAFLD, mitochondrial derived overproduction 
of reactive oxygen species contributes significantly to the oxidative damage 
observed and progression of injury (118). 
 One of the major hypotheses of the Beier laboratory is that VC and its 
reactive metabolites directly cause mitochondrial damage, impairing cellular 
energy homeostasis and sensitizing hepatocytes to other stressors. Indeed, the 
Beier lab has demonstrated that the VC metabolite, CAA, causes mitochondrial 
dysfunction prior to cell death processes being activated. Additionally, data from 
in vivo studies with CE demonstrate that hepatocytes are dying primarily via 
necrosis and not by the ATP-demanding apoptotic pathway. Independent of diet-
induced alterations, several environmental pollutants have also been identified as 
mitochondrial poisons such as dioxin (119) and perfluorooctanoate (120-122).  
Here, the major focus of this study was to determine if direct exposure to VC 
inhalation at sub-OSHA concentrations could incite mitochondrial dysfunction 
and to determine the mechanism by which this occurs.  
B. Experimental Procedures 
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1. Animals and treatments 
6 week old, male C57Bl/6J mice were exposed to sub-OSHA 
concentrations of VC via inhalation or room air in inhalation chambers for 6 hours 
per day, 5 days per week, for up to 12 weeks as described in Chapter II, Section 
A.1. Mice were fed either a low fat diet (LFD) or high fat diet (HFD) as detailed in 
Chapter II, Section A.4. Animals were sacrificed at either 6 or 12 weeks and 
tissues were collected as described in Chapter II, Section A.2.  
2. Mitochondrial isolation  
Hepatic mitochondria were isolated by differential centrifugation as 
described in Chapter II, Section A.5. Mitochondrial protein concentration was 
determined via Lowry Assay using bovine serum albumin as the standard control.  
3. Seahorse analysis 
Seahorse bioenergetic flux analysis was performed on isolated hepatic 
mitochondria as described in Chapter II, Section A.5.  
4. Biochemical analyses 
Plasma levels of lactate and β-hydroxybutyrate were determined using 
commercially available kits as described in Chapter II, Section C.1.  
5. RNA isolation and real time qRT-PCR 
Hepatic mRNA was isolated and quantified as described in Chapter II, 
Section F. Real time-qRTPCR was performed for Tfam, Fis1, Drp1, and Cox4 as 




Whole liver and mitochondrial lysates were isolated and quantified as 
described in Chapter II, Section G. Western blots for OXPHOS complexes, 
phospho-Stat3, total Stat3, IP3-R1, and GAPDH were performed as detailed in 
Chapter II, Section G.  
7. Quantitative cell analysis  
Hepatocytes were isolated and plated as described in Chapter II, Section 
D. Quantitative cell analysis was performed as detailed in Chapter II, Section E. 
8. Statistical analysis 
Results are reported as means ± standard error (SEM, n=4-12) and were 
analyzed using SigmaPlot 11.0 (Systat Software, Inc., San Jose, CA). Unless 
otherwise specified, one-way or two-way ANOVA with Bonferroni’s post-hoc test 
(for parametric data) or Mann-Whitney Rank Sum test (for nonparametric data) 
were used for determination of statistical significance among treatment groups, 
as appropriate. A p value less than 0.05 was selected before the study and the 
level of significance. a, p<0.05 compared to the absence of HFD; b, p<0.05 





1. VC exposure’s temporal effect on mitochondrial gene expression 
In order to determine if VC exposure affected mitochondrial gene 
expression, several markers of mitochondrial biogenesis were examined via 
hepatic mRNA analysis as seen in Figure 5.1. Mitochondria transcription factor A 
(Tfam), mitochondrial fission protein 1 (Fis1), dynamin-related protein-1 (Drp1), 
and cytochrome c oxidase 4 (Cox4) are all critically involved in mitochondrial 
dynamics. No alterations were observed for any of the experimental groups in 
Cox4 or Dmn1 expression at any time point. Interestingly, decreases were 
observed for Tfam and Fis1 expression in animals that were exposed to HFD and 
VC at 6 weeks of exposure (Figure 5.1A). However, these changes were no 
longer observed at the 12 week time point (Figure 5.1B), which may indicate that 
key changes in mRNA expression are mediated early in chronic exposure, 
















Figure 5.1. Effect of VC on mitochondrial gene expression. A: Hepatic mRNA 
expression of Tfam, Fis1, Drp1, and Cox4 are shown as fold of control compared 
to LFD control animals at the 6 week time point. B: Hepatic mRNA expression of 
Tfam, Fis1, Drp1, and Cox4 are shown as fold of control compared to LFD 
control animals at the 12 week time point. a, p<0.05 compared to LFD control; b, 










































































































2. VC decreases mitochondrial protein abundance  
In order to determine if mitochondrial protein levels were altered in this 
model, mitochondrial protein was analyzed by Lowry protein assay from 
mitochondria isolated from mice exposed to VC with or without HFD for 6 and 12 
weeks of exposure (Figure 5.2). At the 6 week time point, there is a significant 
diet effect, with HFD fed animals having more mitochondrial protein compared to 
their LFD control counterparts, an effect that has also been observed by Turner 
et al., (123). However, at the 12 week time point, although there was still a 
significant diet effect, VC significantly decreased mitochondrial protein 
concentrations. Possibly indicating that the mitochondrial damage has become 










Figure 5.2. Effect of VC on mitochondrial protein abundance. Mitochondrial 
protein concentration was determined via Lowry assay for mitochondria isolated 





























































3. VC decreases protein levels of ETC associated complexes 
independent of HFD feeding 
Since no increase in apoptosis in the hepatocyte population was observed 
in spite of increased caspase-3 cleavage (Chapter III), we hypothesize that VC 
may be impacting cells at the level of energy homeostasis. Indeed, previous data 
support this hypothesis. Anders et al., has demonstrated the CAA can cause 
mitochondrial damage and consequential ATP depletion (26). Therefore, in order 
to determine if VC exposure decreases protein levels of components of oxidative 
phosphorylation (OXPHOS), mitochondrial protein isolated from mice exposed to 
VC ± HFD for 6 weeks were analyzed via Western blot. Samples were blotted 
and probed for all five complexes of the electron transport chain (ETC) and 
quantified with total protein (Figure 5.3). Importantly, VC significantly decreased 
protein levels of Complex I, Complex III, Complex IV, and Complex V in the LFD 
group. This indicates that low-level VC exposure is capable of affecting oxidative 
phosphorylation by decreasing protein levels of select complexes. Interestingly, 
HFD alone decreases protein levels of Complex III and Complex V and the 



















Figure 5.3. VC decreased OXPHOS protein levels independent of HFD.        
A: Representative Western blots are shown for components of the ETC from 
mitochondrial isolates at 6 weeks of exposure. B: Coomassie stain for total 
protein is shown for the 6 week time point. C: Densitometric analysis for each 
complex is shown as fold of control compared to LFD control samples. a, p<0.05 















































































4. VC’s effect on mitochondrial respiration capacity  
As previously stated, mitochondrial function is indicative of not only whole 
cell energy homeostasis, but also of altered mitochondrial respiration. Moreover, 
oxidative capacity is a hallmark of several liver diseases. Previous work from this 
group has demonstrated that VC metabolites decrease both oxygen consumption 
and maximum mitochondrial capacity in primary hepatocytes (26). Therefore, the 
effects of VC inhalation on mitochondrial function were examined in this model. 
Seahorse bioenergetic analysis was performed on isolated hepatic mitochondria 
from mice from all treatment groups at 6 weeks of exposure. Figure 5.4 depicts 
the analysis of Complex I, Complex II, and Complex V activity, in addition to 
maximum mitochondrial respiratory capacity. Importantly, independent of diet, 
VC exposure significantly decreased all of these indices. This indicates that VC 
directly impairs hepatic mitochondrial ETC function and respiratory capacity. 
Similar to previous findings (123), mitochondria isolated from HFD fed animals 
had higher respiration over their LFD counterparts. Importantly, VC still impaired 























Figure 5.4. VC decreased mitochondrial respiration.  Seahorse analysis of 
isolated hepatic mitochondria at 6 weeks of exposure and measurements of 
oxygen consumption are shown. Pyruvate/malate/ADP was administered as a 
Complex I substrate, oligomycin was administered as a Complex IV inhibitor, 
FCCP was a mitochondrial uncoupler, and succinate/rotenone was administered 
as Complex II substrates.  
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5. Potential role of phospho-Stat3 and calcium homeostasis 
Mitochondria are dynamic organelles which actively communicate with 
other membrane bound organelles and the nucleus to coordinate cellular 
homeostasis (124). To this end, several signaling pathways are known to be 
modified by alterations in mitochondrial respiration. One such pathway is the 
signal transducer and activator of transcription 3 (STAT3) pathway. STAT3 
phosphorylation at Serine-727 has been shown to non-transcriptionally regulate 
the electron transport chain to increase its activity (125). Here, we evaluated 
STAT3 phosphorylation both for the canonical Tyrosine-705 phosphorylation and 
Serine-727 phosphorylation via Western blot (Figure 5.5A). LFD + VC animals 
show no changes when compared to control animals at the Tyr-705 residue. A 
diet-effect was observed for P-STAT3-705 phosphorylation as seen as a 
decrease in activity, with no VC effect in this group. Upon analyzing Ser-727 
protein levels, LFD + VC did not have a significant effect, although a p-value of 
0.07 suggests that this pathway may be activated. A significant increase is 
observed with HFD feeding, however there is no VC effect for this group.  
In addition to alterations in signaling cascades, mitochondrial dysfunction 
is also associated with aberrant intracellular calcium levels (126;127). Therefore, 
a key mediator of calcium release from the endoplasmic reticulum, IP3-R1, was 
examined via Western blot for whole liver lysates at 6 weeks of exposure (Figure 
5.5B). LFD + VC exposed animals have significantly increased levels of IP3-R1 
protein. HFD alone also caused an increase in IP3-R1 protein, while VC does not 







Figure 5.5. Effect of VC on Stat3 phosphorylation and calcium 
homeostasis. A: Representative Western blot for phospho-STAT3 (Tyr-705 and 
Ser-727) and total STAT3 are shown for the 6 week time point. B: Representative 
Western blot for IP3-R1 are shown for the 6 week time point. C: Densitometric 
analysis was performed and results are presented as fold of control compared to 
LFD control animals. a, p<0.05 compared to LFD control; b, p<0.05 compared to 






























































































6. VC’s effect on lactate and ketone body production 
Due to the observed changes in mitochondrial respiratory capacity, indices 
of both increased glycolysis (lactate, Figure 5.6A) and ketone body production (β-
hydroxybutyrate, Figure 5.6B) were assessed to give additional insight into the 
mechanism of mitochondrial injury. Here, the 12 week time point was used for 
measurements, as this is when the pathological indices were greatest. Plasma 
lactate levels were analyzed as an index of glycolysis. VC significantly enhanced 
lactate levels in the LFD group, while the effect of HFD was not significant. β-
hydroxybutyrate levels were assessed. No differences were observed for LFD 
fed animals with or without VC exposure. HFD did not significantly increase β-























Figure 5.6. Effect of VC on lactate and ketone body production. A: Lactate 
levels were determined from plasma samples at 12 weeks of exposure and are 
represented as mM/L. B: Plasma β-hydroxybutyrate concentrations were 
determined in plasma as an index for ketone bodies for the 12-week time-point 
and results are represented in mM/L. a, p<0.05 compared to LFD control; b, 









































































7. VC sensitizes hepatocytes  
In order to further investigate the effects of VC exposure on mitochondria in 
this model, primary hepatocytes were isolated from animals from each treatment 
group after 6 weeks of exposure and analyzed via Cellomics ex vivo with and 
without the additional challenge of CAA. Figure 5.7 depicts representative 
photomicrographs from animals exposed to LFD ± VC with and without CAA 
challenge. TOTO-3 was used as a marker of cell death and TMRM was used as 
a marker of mitochondrial membrane potential, in which a decrease is indicative 
of mitochondrial damage. Figure 5.8 displays the cell-by-cell analysis and 
quantification that was performed. Notably, LFD + VC exposed hepatocytes 
display increased mortality at baseline, with 41.7% of cell being TOTO-3 positive 
compared to 21.2% in LFD control hepatocytes. Indeed, upon the addition of 
CAA, VC further increases TOTO-3 positivity. Importantly, in hepatocytes 
administered 400µM CAA, VC increases the number of TMRM negative cells 





















Figure 5.7. VC sensitized hepatocytes to cell death. Representative 
photomicrographs are shown for hepatocytes isolated from animals exposed to 
LFD ± VC at 6 weeks of exposure. TMRM (mitochondrial membrane potential), 
TOTO-3 (cell death), and Hoechst (nuclear) fluorescent staining are shown with 
and without CAA challenge.  
 
  














































Figure 5.8. VC’s effect on cell death. A: 2D scatter plots are shown for 
LFD±VC±CAA in which TMRM is depicted as a function of TOTO-3. Thresholds 
were calculated for positive and negative fluorescence of each marker. B: 
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Similarly, hepatocytes from animals exposed to HFD ± VC were also 
analyzed. Figure 5.9A shows representative photographs and Figure 5.9B 
depicts the corresponding cell-by-cell analysis performed. HFD does increase 
cell death at baseline compared to LFD controls with 45.1% showing TOTO-3 
positivity. However, no significant VC effect was observed in these groups, 

















Figure 5.9. Effect of VC on hepatocyte viability with HFD. A: Representative 
photomicrographs are shown for hepatocytes isolated from animals exposed to 
HFD ± VC at 6 weeks of exposure. TMRM (mitochondrial membrane potential), 
TOTO-3 (cell death), and Hoechst (nuclear) fluorescent staining are shown with 
and without CAA challenge. B. 2D scatter plots are shown for HFD±VC±CAA 
exposed hepatocytes in which TMRM is depicted as a function of TOTO-3. 
Thresholds were calculated for positive and negative fluorescence of each 
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Mitochondria are dynamic organelles that are constantly responding to their 
environment to promote cell survival and nutrient homeostasis. Indeed, 
mitochondrial function and morphology are known to be altered both in 
experimental NAFLD and in humans presenting with NAFLD and NASH 
(128;129). Control of mitochondrial biogenesis, fission and fusion, β-oxidation, 
and respiratory function are complex pathways that play key roles maintaining 
mitochondrial integrity. However, this is still an area that is actively being 
investigated, as these pathways have not been fully elucidated. In addition to 
diet-induced mitochondrial dysfunction, environmental toxicants have been found 
to negatively affect mitochondrial function by several mechanisms. For example, 
the VOC acrolein has been shown to decrease mitochondrial membrane 
potential and decrease ETC activity (91;130). Moreover, a recent study 
performed by Dezest et al., has shown that low-level exposure to a VOC mixture 
caused mitochondrial damage in keratinocytes (131). Further, the Beier lab has 
recently demonstrated the mitochondrial toxicity of the VC metabolite, CAA in 
hepatocytes (26). CAA has also been shown to be toxic to mitochondria in the 
context of kidney injury (132;133). However, the effects of direct exposure to VC 
inhalation at low concentrations on mitochondrial integrity and function have not 
been studied and were therefore the goal of this study.  
The experiments conducted in this study analyzed several aspects of 
mitochondrial health and function and yielded that low-level VC exposure does 
indeed impact hepatocytes at the level of the mitochondria. First, the effects of 
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mitochondrial biogenesis was examined by analyzing mRNA expression of Tfam. 
Tfam is critical for mitochondrial biogenesis and maintaining the stability and 
transcription of mitochondrial DNA (134). Here, a decrease in Tfam was 
observed only in animals exposed to HFD and VC at 6 weeks, however, these 
changes were no longer seen at 12 weeks of exposure. Although observed 
earlier during the exposure, the decrease in this important regulator could 
indicate that the combination of VC and HFD has detrimental effects on 
mitochondrial biogenesis, which may lead to later injury observed in this model. 
Secondly, the balance of mitochondrial fission to fusion, that is the joining or 
separation of the organelle, is imperative for regulating mitochondrial 
bioenergetics and removing damage during periods of internal stress (135;136). 
To this point, increased fission, or the separation of mitochondria, has been 
associated with increased oxidative damage (137). Here, although a decrease in 
Fis1 mRNA expression is observed at 6 week of exposure in HFD + VC animals, 
there is a diet-dependent effect for an increase in Fis1 at 12 weeks of exposure. 
Although alterations were observed, future studies are needed to determine the 
exact role of these dynamics in this model.  
Mitochondria are also the site of fatty acid β-oxidative, which is the 
breakdown of fats to provide reducing equivalents necessary for oxidative 
phosphorylation (138). Here, ketone body production was measured as an index 
of β-oxidation capacity. During fasting conditions, β-oxidative capacity increases 
and the surplus of acetyl-CoA produced cannot be utilized by the TCA, so it is 
converted to ketone bodies, such as β-hydroxybutyrate (139). Indeed, here, the 
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animals were subjected to fasting and increased β-hydroxybutyrate levels were 
observed in HFD fed animals. However, because no deficits are observed in 
animals exposed to HFD + VC compared to HFD controls, it suggests that this 
mitochondrial process remains intact and functional (Scheme 5.1).  
Perhaps the most critical function of mitochondria is their production of ATP 
via the electron transport chain (ETC) and oxidative phosphorylation. Here, 
several aspects of mitochondrial respiration and ETC function were assessed in 
the context of low-level VC exposure. Indeed, upon analysis of protein levels of 
ETC complexes, VC significantly decreased several complexes compared to LFD 
control animals. Additionally, VC significantly depressed mitochondrial respiration 
at the functional level as observed from the Seahorse analysis. HFD, however, 
decreased protein levels of certain complexes, an effect which has also been 
observed by Aharoni et al. (140). Paradoxically, the addition of VC in this group 
significantly enhanced protein levels of complexes III and V, which could be 
indicative of a compensatory mechanism. Importantly, despite the increased 
protein levels observed, HFD and VC exposed animals still had significant 
deficits upon functional analysis. This suggests an even stronger net deficit in 
this group. Further, increases in plasma lactate levels support the hypothesis that 
VC-exposed hepatocytes have increased glycolytic flux to compensate for the 
deficits in oxidative phosphorylation production of ATP. Collectively, these data 
suggest that VC exposed hepatocytes have decreased mitochondrial respiratory 
capacity and this has direct consequences on protein levels observed. 
Additionally, VC exposed hepatocytes were shown to be more sensitive to cell 
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death and mitochondrial damage as observed ex vivo in this study. This suggests 
that VC is sufficient to alter hepatocyte response to additional stressors, as they 
are more susceptible to damage.  
A known positive regulator of ETC function is phosphorylated STAT3 at 
Serine-727 (141). Serine-727 activity has been documented as conferring 
protection against ETC damage and inducing an increase in oxidative 
phosphorylation. Here, a trend is observed for increased Serine-727 
phosphorylation in LFD + VC exposed animals at 6 weeks, the same time point 
evaluated for the functional analysis. Interestingly, although a significant diet-
induced increased is observed, VC does not increase this effect. This may 
indicate that the combination of HFD and VC activate and progress via different 
stress/metabolic pathways or could be demonstrative of exhaustion of this 
pathway. However, further experiments need to be conducted to determine the 
exact mechanism involved, but the activation of this signaling pathway may be a 















Scheme 5.1. Proposed effect of VC on mitochondrial function. Upon 
exposure to VC, reactive intermediates form though bio-activation processes and 
diet-induced obesity decreases their elimination. VC/VC metabolites directly 
impair ETC complex activity, which impairs oxidative phosphorylation. This 
increases the demand for ATP via glycolysis. The increased demand for glucose 
dysregulates metabolic homeostasis and depletes glycogen stores. Enhanced 
macrovesicular steatosis occurs, leaving β-oxidation of FFA intact, even under 
conditions of ATP depletion. The decreased mitochondrial potential facilitates 
cytochrome c release to activate apoptotic cascades, however the loss of ATP 
results in incomplete apoptosis and necrotic cell death. The combined metabolic 
stress of VC exposure causes increased oxidative stress, ER stress, and 
inefficient mitochondrial respiration and energy production, resulting in increased 






























DISCUSSION AND CONCLUSIONS 
 
A. Restatement of goals and questions 
The major goal of the work described in this dissertation was to expand on 
the unifying hypothesis that chronic exposure to sub-OSHA concentrations of VC 
is not only sufficient to exacerbate high fat diet-induced liver injury, but is capable 
of sensitizing hepatocytes via metabolic and mitochondrial dyshomeostasis. The 
Beier group has previously demonstrated the merit of evaluating the impact of 
sub-hepatotoxic exposures to VC metabolites in combination with other 
mitigating factors (i.e. inflammation and diet) (26;27). The experiments conducted 
in Chapter III describe a novel mouse model in which the effects of chronic VC 
inhalation can be evaluated in conjunction with exposure to a HFD; thereby, 
aiding in the characterization of nutrient:toxicant mechanisms of liver damage. 
Chapter IV characterized the alterations in hepatic metabolism after exposure to 
VC alone and described enhancement of both oxidative and ER stress pathways 
with the combination of a HFD and VC exposure. Finally, Chapter V investigated 
the effect of VC exposure on mitochondrial integrity and function, thereby 
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providing key insight into the mechanism of VC-induced hepatocyte injury. Taken 
together, these studies provide novel information into the complex mechanism of 
VC-induced hepatotoxicity and its ability to concomitantly enhance underlying 
liver injury. 
B. Major findings of this dissertation  
1. Chronic, low-level VC exposure enhances liver injury caused by a 
HFD feeding 
Previous studies from the Beier laboratory have established that exposure 
to VC metabolites can enhance liver injury caused by both an inflammatory 
stimulus (LPS) and by metabolic disruption (HFD) in mouse models of exposure. 
Additionally, occupational exposures to extremely high levels of VC are known to 
produce both cancerous and non-cancerous liver diseases. However, the effect 
of low-level exposures to VC in the context of pre-existing liver injury has not 
been studied. As such, the goals of Chapter III were to 1.) Develop and 
characterize a mouse model for simultaneous exposure to sub-OSHA VC levels 
via inhalation and HFD feeding to better mimic human exposures, 2.) Evaluate 
indices of liver injury and inflammation to determine if VC exposure enhances 
diet-induced liver injury, and 3.) Determine the predominant mechanism of 
hepatocyte cell death in this model.  
The first goal of Chapter III was to develop and characterize this model of 
VC inhalation and concomitant HFD feeding. Mice were exposed to sub-OSHA 
concentrations of VC (<1 ppm) in an inhalation chamber, whilst being fed either a 
low fat control diet or a high fat diet. In order to determine overall animal health 
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during the study, measurements of body weight, food consumption, and liver to 
body weight ratios were measured for each time point of exposure. Interestingly, 
although there was a diet-dependent effect on weight gain and liver to body 
weight ratios, VC did not enhance these indices as originally hypothesized. 
Additionally, VC did not alter body mass composition as determined via both fat 
and lean mass measurements. Importantly, no significant effect was observed in 
animals exposed to LFD + VC, indicating that this concentration of VC alone 
does not alter whole organism health.  
A second major goal of Chapter III was to evaluate indices of liver injury to 
determine if VC exposure enhanced damage caused by a HFD. HFD feeding is 
known to cause NAFLD-associated pathologies in mice such as increased 
steatosis and elevated transaminase levels. Indeed, the studies conducted in 
Chapter III show that HFD + VC exposed animals had significantly higher levels 
of hepatic transaminases and increased fibrin accumulation. Fibrin can be 
indicative of increased tissue injury by activation of the coagulation cascade. 
Indeed, upon a more in depth analysis, it was determined that the increased 
fibrin accumulation observed was due to enhanced thrombin activity. To address 
the changes in overall liver injury observed, markers of hepatic inflammation 
were also examined. In addition, visualization of both hepatic neutrophil 
infiltration and macrophage recruitment was performed via histology. VC 
significantly increased hepatic neutrophil accumulation in the HFD group, while 
no changes were observed for any treatment group in regards to macrophage 
recruitment. This may indicate a neutrophil-dependent inflammatory response in 
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this model. Indeed, neutrophils are important innate immune mediators of local 
tissue injury and could be responding to the increase in tissue fibrin, as fibrin is a 
known attractant for neutrophils. However, intriguingly, VC did not alter protein 
levels of key cytokines involved in inflammation.  
Finally, Chapter III sought to determine the major cell death pathway that 
occurs in this model. Historically, VC/VC metabolite exposure has been 
associated with necrotic cell death (26;34). The results presented from this study 
coalesce with the previous studies. Here, although there is a significant increase 
in caspase-3 cleavage with the combination of HFD and VC, there is not an 
increase in apoptotic hepatocytes as evidenced by TUNEL staining. Interestingly, 
there is a significant increase in NPCs undergoing apoptosis (e.g. macrophages) 
suggesting increased turnover or damage to this cell type specifically. As stated 
previously, it is important to note that LFD + VC exposed animals did not have 
any signs of liver injury or increased cell death in this model at 12 weeks of 
exposure. Again, this indicates that the concentration of VC does not overtly 
damage hepatocytes, but in conjunction with another stressor (diet), VC 
significantly enhanced hepatic injury.   
2. VC exposure dysregulates hepatic metabolism and increases 
endogenous stress 
As described in Chapter I, Section 4, liver disease progression to more 
severe pathologies is a complex and incompletely understood. In the seminal 
study by Cave et al., occupationally exposed VC workers had altered plasma 
insulin levels, indicating perturbed nutrient signaling (34) and a recent study 
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revealed highly exposed VC factory workers had significant changes to their 
plasma metabolome (79). Therefore, the driving hypothesis behind Chapter IV 
was that metabolic changes induced by VC exposure that may not be overtly 
toxic, but may contribute to development of more severe liver disease, is critical 
to understand the pathogenicity of VC exposure, especially at low-level 
concentrations. Additionally, examining the effect of VC on known pathways 
involved in NAFLD could provide mechanistic insight to VC hepatotoxicity. 
Therefore, Chapter IV of this dissertation aimed to 1.) Determine if VC inhalation 
exposure alone causes alterations in hepatic metabolism, and 2.) Evaluate the 
impact of VC exposure on both oxidative and ER stress processes as potential 
mechanisms by which VC enhances diet-induced liver damage.  
In order to achieve the first goal of Chapter IV, histological indices of lipid 
(ORO) and carbohydrate (PAS) metabolism were examined for the same time 
point in which the enhanced hepatic injury was observed at 12 weeks of 
exposure. Hepatic lipids were also analyzed to give a more detailed breakdown 
of the increased lipid accumulation observed via the ORO stain. Indeed, a 
significant accumulation of macrovesicular lipids were observed as evidenced by 
liver triglyceride content in animals which were exposed to both HFD and VC. 
Interestingly, although VC did not cause changes in hepatic lipids in the absence 
of a HFD, it did significantly deplete hepatic glycogen reserves, which indicates 
alterations in carbohydrate, specifically glucose, metabolism. Looking to an 
earlier time point (6 weeks) to provide mechanistic insight to this phenomenon, 
mRNA expression of key glucose regulating enzymes was analyzed. Indeed, 
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LFD + VC exposed animals showed significant increases in the enzymes 
evaluated (e.g., Pck1, G6Pase, Pgc1α), suggesting that VC exposure disrupts 
cellular and whole organism (PTT results) glucose homeostasis.  
Secondly, Chapter IV sought to investigate VC’s effect on oxidative stress 
and ER stress pathways as possible mechanisms by which enhanced liver injury 
was observed with the co-exposure of HFD and VC (see Chapter III). To 
accomplish this, the studies performed analyzed histological and biochemical 
indices of hepatic oxidative stress. Results from these analyses determined that, 
in fact, low-level VC exposure significantly enhanced HFD-induced lipid 
peroxidation adducts, such as 4-hydroxynonenal (4-HNE) and malondialdehyde 
(MDA). Importantly, significant increases in 4-HNE positive staining were also 
observed for LFD + VC exposed animals, indicating that chronic, sub-OSHA 
exposures to VC alone is sufficient to induce biomolecular damage. As 
mentioned in Chapter I, Section 3, it is also likely the reactive metabolites of VC 
are the perpetrators of such damage as they are known to covalently bind to and 
damage both DNA and protein (19;21;22). Further, as part of the second goal of 
Chapter IV, several markers of ER stress activation were analyzed and electron 
microscopy was performed to macroscopically determine damage. Importantly, 
independent of diet at 12 weeks of exposure, there is compelling evidence of 
UPR activation via morphology changes to ER (e.g., ER dilation). Interestingly, 
significant, but minor changes in mRNA expression of key ER stress executors 
are observed, with no changes at the protein level. This suggests that other 
potential mechanisms of regulation may be involved. Taken together, the results 
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from Chapter IV suggest that VC metabolically sensitizes hepatocytes to 
secondary stressors, and although increased oxidative adducts and modest 
alterations to the ER are observed, it is likely that these are secondary 
pathologies which aid in/result from the metabolic and energy disruption 
observed in this model.  
3. VC exposure targets the ETC and decreases mitochondrial 
function 
Mitochondria are dynamic organelles capable of adapting to changes in 
cellular energy supply and responding to both endogenous and exogenous 
stressors in order to maintain homeostasis. Importantly, as they are crucial for 
maintaining cellular energy levels via ATP production, damage to this organelle 
often has profound consequences. Perturbations in nutrient homeostasis result in 
mitochondrial dysfunction. Both NAFLD and toxicant exposure have 
independently been shown to induce morphologic and functional changes in 
hepatic mitochondria. Therefore, the goals of Chapter V were to 1.) Investigate 
the role of low-level VC exposure on mitochondrial function and the impact of 
HFD and, 2.) Determine a mechanism by which VC exposure impacts 
mitochondrial integrity and energy production.  
In order to accomplish the first goal, this study examined mRNA expression of 
key genes involved in mitochondrial biogenesis and organelle dynamics in 
addition to analyzing mitochondrial protein concentrations at both 6 and 12 
weeks of exposure to VC with and without a HFD. Interestingly, decreases in 
mRNA expression of Tfam are seen at 6 weeks of VC exposure in the HFD and 
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VC exposed animals, suggesting impaired mitochondrial biogenesis. Additionally, 
alterations were observed in Fis1 mRNA expression which varied depending on 
the time point examined. This is coupled with observations of a significant VC 
effect on mitochondrial respiration as seen via a functional assay on isolated 
hepatic mitochondria at 6 weeks of exposure independent of diet. Indeed, these 
data support the hypothesis of Chapter V, which is that low-level VC exposure is 
sufficient to cause effects at the mitochondrial level.  
The second goal of Chapter V was to determine a possible mechanism by 
which the functional deficits were observed. To accomplish this, several proteins 
were examined via Western blot. Indeed, decreases were observed in several 
ETC complexes with VC exposure alone, indicating a direct effect on 
mitochondrial protein levels. Phosphorylated STAT3 at Serine-727 was examined 
as a possible signaling pathway at play in this model. Significant changes were 
observed at this phosphorylation site, suggesting that this pathway may be 
important in VC-induced mitochondrial damage. Further, VC was shown to cause 
hepatocytes to be more susceptible to cell death and mitochondrial damage in 
LFD fed animals.  
4. Significance of new findings 
The work presented in this dissertation has aided in filling a crucial knowledge 
gap regarding low-level VC exposure and its impact on existing liver injury 
caused by diet. The work presented herein sought to characterize a novel model 
of VC exposure that is currently below the OSHA regulation limit (<1 ppm) and its 
impact in a co-exposure paradigm with experimental NAFLD. As discussed in 
106
 
Chapter I, potential for VC exposure remains prevalent as its current ranking as 
4th on the ATSDR Hazardous Substance List attests to. Exposures at or below 
the OSHA limit are relevant not only for occupationally exposed workers, but also 
for populations living in areas surrounding both PVC producing facilities and EPA 
designated Superfund sites. An ever-growing concern globally and in the United 
States is the prevalence of obesity and NAFLD. Indeed, 25% of the global is 
estimated to have underlying NAFLD.  
The experiments presented in Chapter III suggest a novel interaction between 
HFD and sub-OSHA exposures to VC via inhalation. The data presented in 
Chapter III demonstrate that the combination of VC inhalation and HFD feeding 
does not increase adiposity via obesogenic mechanisms at 12 weeks as some 
environmental pollutants are known to do (70). Although no changes in body 
weight gain or liver weight were observed with VC and HFD exposure, there 
were significant increases in indices of liver injury. Enhanced liver injury was 
observed as evidenced via increased liver enzymes, fibrin accumulation, and 
neutrophil infiltration all suggest that VC exposure enhances diet-induced liver 
damage. It is important to note that animals exposed to the same concentration 
of VC on a LFD did not have any signs of hepatic injury, indicating that the 
‘multiple-hit’ paradigm of liver injury holds true in these studies. A second 
interesting result from the studies conducted in Chapter III reveal a differential 
effect of HFD and VC exposure on hepatic cell death. Similar to other studies 
with VC/ VC metabolites, it appears as though the primary route for hepatocyte 
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cell is not via apoptosis, despite increases in caspase cleavage and cytochrome 
c release from mitochondria.  
The profound enhancement of liver injury observed in the combination of 
HFD and VC exposure prompted the study for mechanistic insight. Therefore, the 
experiments in Chapter IV provided key information regarding the hepatotoxicity 
of low-level VC exposure, both with and without the addition of HFD feeding. 
Indeed, the results gathered in Chapter IV suggest that VC exposure alone is 
sufficient to cause both metabolic and oxidative damage to hepatocytes. 
Importantly, these ‘sub-hepatotoxic’ alterations may be crucial in sensitizing 
hepatocytes to further injury. Sub-OSHA exposure to VC significantly altered 
hepatic glucose metabolism by causing a shift to increase systemic 
gluconeogenesis to compensate for decreased cellular ATP production (see 
below). Additionally, increased indices for oxidative stress and ER stress were 
observed in animals co-exposed to HFD and VC. Therefore, Chapter IV 
describes a novel potential mechanism by which low-level VC exposure 
enhances diet-induced liver injury.  
Finally, Chapter V of this dissertation sought to develop the hypothesis 
that low-level VC exposure may directly damage mitochondrial function and the 
impact that HFD co-exposure may have on this effect. The experiments 
described in Chapter V demonstrate that low-level VC exposure is sufficient to 
induce mitochondrial damage as seen via decreased respiratory capacity at 6 
weeks of exposure and decreased protein levels of key oxidative phosphorylation 
enzymes. Additionally, VC alone was observed to decrease cell viability 
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compared to LFD control animals at 6 weeks, suggesting that VC exposed 
hepatocytes are more susceptible to secondary damage. These data suggest a 
novel role for VC as an important risk-factor for developing liver disease. Notably, 
accumulating damage from adducted proteins, metabolic stress, and 
mitochondrial deficits all contribute to increased hepatocyte susceptibility to 
enhanced injury when combined with another stressor. This was demonstrated in 
this dissertation by co-exposure with a HFD to mimic NAFLD. Taken together, 
the results presented here provide new insight into low-level VC-induced 
hepatotoxicity and its potential for increasing liver injury when combined with 
experimental NAFLD.  
C. Strengths and Weaknesses 
1. Strengths  
There are several strengths of the work presented in this dissertation. 
First, this work developed and used an animal model that more closely mimics 
human exposure to environmental VC exposures and concomitant exposure to a 
diet high in saturated fat. As mentioned previously, the field of environmental 
toxicology is shifting towards an ‘exposure biology’ approach which takes into 
account multiple factors when evaluating risk for developing disease. To this 
point, development of liver damage and disease progression is a complex 
process with multiple confounding factors. Therefore, the hypothesis evaluated 
here could likely not be sufficiently addressed by the use of simpler model 
systems (e.g., cultured cells). Particularly, this work used an animal model, in 
which chronic administration of sub-OSHA concentrations of VC exposure were 
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used. This is a major strength of this work. The results from these studies provide 
additional support for the continued research into environmentally relevant 
toxicant exposures and the impact they have on underlying liver injury.  
Another strength of this work is the incorporation of state-of-the-art 
techniques in order to gain novel insight behind the mechanisms of VC 
hepatotoxicity. Indeed, these studies revealed the importance of VC exposure on 
hepatic metabolism, oxidative stress activation, and mitochondrial dysfunction. 
Importantly, this work has demonstrated that not only does VC independently 
cause hepatocytes to be more susceptible to further damage, but that 
concomitant exposure to experimental NAFLD significantly enhances liver injury 
and oxidative damage. These findings are critical as they demonstrate that 
current OSHA exposure thresholds may not be stringent enough given the 
prevalence of NAFLD in this country and around the world.  
Finally, this dissertation has identified that sub-OSHA concentrations of 
VC are sufficient to cause functional deficits in hepatic mitochondria without the 
addition of a second factor. Building on previous work done with VC metabolites 
in vitro, this dissertation sought to determine the effects of VC exposure in a 
more relevant exposure paradigm. The experiments in Chapter V demonstrated 
the sensitivity of hepatic mitochondria to VC toxicity. While it is known that 
mitochondrial damage occurs in human populations with NAFLD and NASH, the 
findings herein reiterate that populations exposed to low-level VC concentrations 
may be uniquely susceptible to enhanced liver injury caused by diet.  
2. Weaknesses  
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Although the animal model used in this dissertation is a key strength to 
this work, it is also a source of potential complexity. With increasing complexity of 
the model system, there is also an increase in uncertainty regarding mechanisms 
as play. Indeed, there is currently no rodent model that completely recapitulates 
human fatty liver disease progression or response to toxicants. It is therefore 
possible that the injury and metabolic alteration observed in this model are not 
applicable to human populations.  
The work presented here has identified several potential mechanisms by 
which VC causes and enhances liver injury. However, due to the complexity of 
the factors at play, it is difficult to discern the exact pathways. To this point, a 
simpler model system would be ideal to investigate mechanistic details that are 
confounded in this murine model. Further, only male mice were used in this 
study. It is important to note the effects observed may vary with sex. Another 
source of potential weakness of work can be found within the exposure time line 
and time points chosen for sacrifice. Indeed, results from this work highlight the 
temporal changes associated with chronic VC exposure in mRNA expression that 
are no longer observed at the later time point of 12 weeks. Therefore, it is 
necessary to consider time points earlier than 6 weeks to evaluate injury and 
stress pathway activation. Additionally, time points past 12 weeks of exposure 
should be evaluated to examine continued effects of VC exposure and its 
potential to cause injury. The experiments described in Chapter V in which 
mitochondrial protein are analyzed used only crude mitochondrial extracts. 
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Therefore, it is important to note that isolating pure mitochondria may yield 
different results.  
D. Future Directions  
While the experiments described in this dissertation aided in filling knowledge 
gaps regarding chronic, low-level VC exposure and its potential to enhance 
underlying liver disease, it has also opened the door for new research questions 
which will need to be addressed in future studies. Some of these questions are 
addressed below.  
1. Does VC exposure cause mitochondrial protein adducts?  
The experiments described in Chapter V were mainly concerned with 
determining the functional effect of VC exposure on mitochondrial respiration and 
integrity. Although some alterations were observed at the mRNA and protein 
level, the most profound effect of VC could be seen at the level of mitochondrial 
function. As previously mentioned, the VC metabolite CAA is known to propagate 
intracellular damage via adducting proteins. Therefore, an interesting future study 
would be to perform a global mitochondrial proteomics analysis to determine if 
VC exposure induces covalent adduct formation, thereby decreasing 
mitochondrial function, while explaining why protein levels are not dramatically 
changing in this model. 
2. Does VC exposure alter mitochondrial-ER membrane interactions?  
Mitochondria and the endoplasmic reticulum (ER) communicate with each 
other through mitochondrial associated ER membranes (MAMs), sharing 
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metabolites and key signaling molecules (142). Recently, Arruda et al., have 
demonstrated that an increase in MAMs leads to mitochondrial dysfunction in 
HFD fed mice (143). Alterations in MAMs have also been implicated in regulating 
hepatocyte glucose metabolism (144) and in insulin resistance (145;146). 
Indeed, results from Chapter V of this dissertation regarding an increase in IP3-
R1 protein levels with VC exposure give rise to the hypothesis that VC may be 
altering mitochondrial-ER cross talk and calcium homeostasis, contributing to 
hepatocyte injury and metabolic dyshomeostasis. Therefore, it would be of 
interest to investigate further whether enhanced mitochondria-ER contact and 
dysregulated calcium signaling is at play in this model.  
3. Will prevention of mitochondrial dysfunction protect against VC-
induced hepatotoxicity? 
The results from Chapter V clearly demonstrate that VC-induced 
mitochondrial dysfunction may be a driving factor in injury progression especially 
when combined with a secondary factor. Therefore, it would be of great interest 
to determine if ameliorating mitochondrial damage could mitigate injury 
progression in this model. Several mitochondrial protective small molecules are 
being studied due to their antioxidant capabilities and ability to prevent liver 
injury. Indeed, several studies investigating the antioxidant Tempol have 
demonstrated its protective qualities in models of carbon tetrachloride induced 
liver injury (147;148). Further, a small antioxidant peptide, SS-31, has been 
evaluated for its protective qualities. SS-31 is cell permeable and localizes 
specifically to the inner mitochondrial membrane where it scavenges reactive 
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oxygen species, preventing damage. Indeed, studies have shown that SS-31 
administration is protective in hepatic ischemia/reperfusion injury (149;150), 
kidney injury (151), and in experimental models of Parkinson’s disease (152). 
Therefore, using one of these molecules or a compound that confers similar 
effects would be useful in determining a more specific mechanism of VC-induced 
hepatotoxicity.  
4. Does VC alter epitranscriptomic regulation of mRNA expression? 
The results from this dissertation reveal that although VC induces hepatic 
changes and enhances diet-induced liver injury, the corresponding mRNA and 
protein analyses performed do not yield the expecting alterations observed. It is 
therefore possible that VC exposure causes changes to the ‘epitransciptome’. 
Indeed, it has recently been characterized that, similar to DNA, mRNA can be 
post-translationally modified. These modifications such as mRNA secondary 
structure stability and chemical modifications (i.e., methylation and acetylation) 
are able to influence cellular processes independent of mRNA abundance, per 
se. These modifications may also alter RNA-protein interactions and can 
influence response to environmental stressors(153;154). Moreover, preliminary 
data show significant VC-induced alterations in key enzymes involved in 
epitranscriptomic regulation. Based on the observations of this dissertation, it 
would be interesting to pursue the epitranscriptomic involvement in this model 
and identify novel mechanisms of VC hepatotoxicity.  
E. Summary and Conclusions  
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Taken together, this dissertation describes a novel interaction between 
chronic, environmentally relevant exposures to the prevalent hepatotoxicant, VC, 
and its potential to increase liver injury when combined with experimental 
NAFLD. The experiments described in Chapter III underscore the need for 
research regarding low-level toxicant co-exposure with other risk factors. Here, 
experimental NAFLD was used due to its high prevalence in the United States 
and worldwide. Indeed, the combination of diet and VC exposure significantly 
enhanced indices of liver injury. Chapter IV describes potential mechanisms by 
which this injury is observed. Certainly, metabolic stress, ER stress, and 
oxidative damage are major contributors to the hepatic damage observed in this 
model. However, Chapter V revealed that VC-induced mitochondrial damage is 
likely the driving force behind the pathology observed. A decrease in 
mitochondrial integrity and respiration severely compromises VC-exposed 
hepatocytes and their ability to combat secondary stressors, culminating in 
overwhelming injury and cell death. Importantly, this work reinforces the 
relevance of environmental toxicant exposure and raises concerns that the 
current regulations in place may not be stringent enough given the health status 
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ALD  Alcoholic liver disease 
ALT  Alanine aminotransferase 
ANOVA Analysis of variance 
AST  Aspartate aminotransferase 
Atf4  Activating transcription factor 4 
ATSDR Agency for toxic substance disease registry 
BMI  Body mass index 
CAA  Chloroacetaldehyde 
CAE  Chloroacetate esterase  
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CEO  Chloroethylene oxide 
CHOP  Ccat-enhancer-binding protein homologous protein 
Cox4  Cytochrome C oxidase 4 
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DEXA  Dual x-ray absorptiometry  
Dgat2  Diacylglycerol O-acyltransferase 2 
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Drp1  Dynamin related protein-1 
ECM  Extracellular matrix 
ELISA  Enzyme-linked immunosorbent assay 
EM  Electron microscopy 
ER  Endoplasmic reticulum 
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FFA  Free fatty acids 
Fis1  Mitochondrial fission protein 1 
G6Pase Glucose-6-phosphotase 
Gsk3β Glycogen synthase kinase 3 beta 
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Hsp90  Heat shock protein 90 
IL-6  Interleukin-6 
ITT  Insulin tolerance test 
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MAM  Mitochondrial associated ER membrane 
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MCP-1 Monocyte chemotactic protein-1 
MDA  Malondialdehyde 
NAFLD Non-alcoholic fatty liver disease 
NASH  Non-alcoholic steatohepatotis 
NPC  Non-parenchymal cell 
OGTT  Oral glucose tolerance test 
ORO  Oil Red-O 
OSHA  Occupational safety and health administration 
OXPHOS Oxidative phosphorylation 
Pai-1  Plasminogen activator inhibitor 1 
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PTT  Pyruvate tolerance test 
PVC  Polyvinyl chloride  
RER  Respiratory exchange ratio 
ROS  Reactive oxygen species 
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STAT-3 Signal transducer and activator of transcription factor 3 
TAFLD Toxicant-associated fatty liver disease 
TASH  Toxicant-associated steatohepatitis  
TAT  Thrombin anti-thrombin 
TBARS Thiobarbituic acid reactive substances 
Tfam  Mitochondrial transcription factor A 
TG  Triglyceride  
TNFα  Tumor necrosis factor alpha 
VC  Vinyl chloride 
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